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Abstract 
Background:  Chronic cough is a common health problem with variable success rates to 
standardized treatment.  Psychologic symptoms of depression, anxiety, and stress have been 
reported in association with chronic cough.  The purpose of this study was to examine changes in 
the psychologic symptoms of depression, anxiety, and stress in adults with chronic cough 3 
months after management using the ACCP cough treatment guidelines.  
Methods:  This study used a descriptive longitudinal observation design. The major tenets 
associated with the Theory of Unpleasant Symptoms were examined. Intervention fidelity to the 
study components was measured.   
Results:  A sample of 80 consecutive patients with chronic cough of greater than 8 weeks 
duration was recruited from one cough specialty clinic. Mean age of subjects was 58.54 years; 
68.7% were female; 98.7% were white, and 97.5% were non-smokers.  Mean cough duration 
was 85.99 months and mean cough severity was 6.11 (possible 0 –10; higher scores equal greater 
cough severity). Cough severity improved post treatment (n=65, M=2.32, (SE =.291), t (64) 
=7.98, p=.000); cough-specific quality-of-life also improved (n=65, M=9.17, (SE=1.30), t (64) 
=7.02, p=.000).  Physiologic (urge-to-cough r=.360, ability to speak r=.469) and psychologic 
factors (depression r=.512, anxiety r=.507, stress r=.484) were significantly related to cough-
specific quality-of-life and to cough severity (urge-to-cough r=.643, ability to speak r=.674 and 
depression r=.356, anxiety r=.419, stress r=.323) (all r, p=.01); social support and number of 
diagnoses were not related to either variable. Those experiencing greater financial strain had 
worse cough severity. Women, those experiencing financial strain, and those taking self-
prescribed therapy had worse cough-specific quality-of-life.   Intervention fidelity to the study 
plan was rated as high according to observation, participant receipt, and patient/physician 
 vii 
concordance.  Qualitative review identified potential areas of variability with intervention 
fidelity. 
Conclusions:  By measuring the factors related to the major tenets of the Theory of 
Unpleasant Symptoms, this theory has helped to explain why those with chronic cough may have 
symptoms of depression, anxiety, and stress and why these symptoms improve as cough severity 
and cough-specific quality-of-life improve.  Moreover, by measuring intervention fidelity, it may 
be possible to determine why cough guidelines may not be yielding consistently favorable 
results.  
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CHAPTER 1 
State of the Science 
Introduction  
Patients presenting with the symptom of cough comprise the most common reason for 
seeking medical attention in ambulatory settings in the United States (US) resulting in 29, 804, 
000 visits (5%) of the overall 1,083,215,000 medical visits reported for all ages in 2007 (Hing, 
Hall, Ashman, & Xu, 2010) .  While frequency data are lacking and definitions of chronic cough 
vary in the literature, chronic cough has been identified as one of the most common reasons for 
new patient visits to a pulmonary outpatient practice (Altman & Irwin, 2010; Irwin, Baumann, et 
al., 2006; Morice et al., 2007).  Moreover, it has been suggested that if only two percent of 
annual cough-related visits were for chronic cough this would represent 2,166,430 people (Hing 
et al., 2010; Hsiao, Cherry, Beatty, & Rechtsteiner, 2010). Data exist that suggest why chronic 
cough is a major health problem. Patients with chronic cough have reported some of the 
problems associated with their cough as including: feeling that something is seriously wrong or 
worry (Everett, Kastelik, Thompson, & Morice, 2007; Irwin & Curley, 1991), anger (Everett et 
al., 2007; Kuzniar, Morgenthaler, Afessa, & Lim, 2007), ability to speak impaired (Kuzniar et 
al., 2007; Vernon, Leidy, Nacson, & Nelsen, 2009), exhaustion (Irwin & Curley, 1991; Kuzniar 
et al., 2007), self consciousness (Irwin & Curley, 1991; Vernon et al., 2009), inability to 
participate in usual social activities (Everett et al., 2007; Kuzniar et al., 2007) , frustration 
(Everett et al., 2007; Kuzniar et al., 2007), insomnia (Everett et al., 2007; Irwin & Curley, 1991; 
Vernon et al., 2009), need to change life-style or habits (Everett et al., 2007; Irwin & Curley, 
1991; Kuzniar et al., 2007), hoarseness (Irwin & Curley, 1991; Kuzniar et al., 2007), fatigue 
(Everett et al., 2007),  urinary incontinence (Everett et al., 2007; Irwin & Curley, 1991; Kuzniar 
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et al., 2007), and urge-to-cough (Vernon et al., 2009).  Additionally, studies have demonstrated 
the adverse impact of cough on health related quality-of-life as well as significant improvement 
in the same when the symptom is successfully treated (Baiardini et al., 2005; S. S. Birring et al., 
2003; C. T. French, Irwin, Fletcher, & Adams, 2002).   
The Theory of Unpleasant Symptoms can be useful in understanding the role of the 
symptoms of depression, anxiety, and stress and the role of social support as they relate to the 
symptom of chronic cough and its impact on quality-of-life (Lenz, Pugh, Milligan, Gift, & 
Suppe, 1997).  This theory proposes that physiologic, psychologic, and situational factors 
influence symptoms and that the symptoms influence quality-of-life.  The theory also proposes 
that the presence of more than one symptom can result in each acting as a catalyst for the other 
(Lenz et al., 1997). No studies were found that address the role of both psychologic factors and 
social support as influencing chronic cough and its effects on cough-specific quality-of-life. 
Studies using various measures of psychologic status have reported symptoms of 
depression (Dales, Spitzer, Schechter, & Suissa, 1989; Dicpinigaitis, Tso, & Banauch, 2006; 
McGarvey et al., 2006), and anxiety (Dales et al., 1989; McGarvey et al., 2006) as being present 
in association with chronic cough. The psychologic factor stress has also been reported in 
association with chronic cough (Lin, Chen, Hong, & Lin, 2010).  The support of others or social 
support may be a situational factor that can influence the symptom of cough.  Addressing social 
support may be useful in the case of chronic cough associated with symptoms of depression, 
anxiety and stress.  Social support has been cited as being important in ameliorating the negative 
effects of psychologic factors on both mental and physical health (Broadhead, Gehlbach, 
deGruy, & Berton, 1989; Broadhead, Gehlbach, Gruy, & Berton, 1988).   
The American College of Chest Physicians (ACCP) has published guidelines to assist 
healthcare providers in the diagnosis and management of cough (Irwin, Baumann, et al., 2006).  
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These guidelines provide three separate diagnosis and treatment algorithms that categorize cough 
based upon duration of the symptom (Irwin, Baumann, et al., 2006).  The three categories of 
cough described in the ACCP guidelines include acute, subacute, and chronic duration (Irwin, 
Baumann, et al., 2006).  The success rates reported in association with the use of the chronic 
cough diagnosis and management guidelines such as those provided by the ACCP have varied 
widely (Irwin, 2010).  The use of intervention fidelity measures, such as a manual outlining the 
interventions to be employed and observer and participant checklists used to measure the 
adherent and competent delivery  and receipt of the proposed management interventions (Bellg 
et al., 2004; Santacroce, Maccarelli, & Grey, 2004), have not been reported in studies of chronic 
cough.  Thus, the wide variation in success rates reported in the treatment of chronic cough could 
be related, at least in part, to variability in intervention fidelity.  
The purpose of this study was to describe changes in the symptoms of depression, 
anxiety, and stress in adults with chronic cough after management using the ACCP guidelines.  
The Theory of Unpleasant Symptoms (Lenz et al., 1997) was used to  guide this study (see 
chapter 2 for details).   
The specific aims of this study were to:   
1. describe the change in psychologic factors  represented by symptoms of depression, 
anxiety, and stress from baseline to 3 months post initiation of standardized treatment 
for chronic cough;  
2.  determine the relationship between baseline cough severity and cough-specific 
quality-of-life with baseline urinary incontinence, financial strain, employment; self 
prescribed remedy, gender, marital status, and education. 
3. determine the influence of physiologic factors (ability to speak without coughing, 
urge- to-cough and number of diagnoses), situational factors (social support), and 
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psychologic factors (symptoms of depression, anxiety, and stress) on cough-specific 
quality-of-life and cough severity (global symptom/cough measure of timing, 
intensity, distress, and quality) at baseline and at 3 months post standardized 
treatment.   
4. describe the process of measuring intervention fidelity in the application of the ACCP 
guidelines for managing cough using the Technology Model.   
Several research hypotheses derived from the theory of unpleasant symptoms were tested 
to address the previous specific aims.   These hypotheses included: 
a. Treatment of chronic cough using the ACCP guidelines will result in improvement in 
cough severity and subsequently improvements in cough-specific quality-of-life.  
Collectively these improvements will result in improvements in psychological factors, 
physical factors, and situational factors.  
b. Physiologic factors (ability to speak without coughing, urge- to-cough and number of 
diagnoses), situational factors (social support), and psychologic factors (symptoms of 
depression, anxiety, and stress) predict cough severity (timing, intensity, distress, and 
quality) 
c. Cough severity (timing, intensity, distress and quality) predicts cough-specific 
quality-of-life and, collectively if improvements are found in cough severity and 
therefore in quality-of-life they will result in improvements in psychologic, 
physiologic, and situational factors. 
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Background and Significance 
Chronic Cough: The Symptom 
Cough is as a mechanism of defense that is important in keeping the airways clear of 
harmful substances or as a problematic symptom or self perceived indicator of ill health (Irwin, 
Baumann, et al., 2006).  This study will focus on chronic cough as a symptom that can pose a 
substantial burden for patients.  Resolution of the symptom of cough is important to patients. The 
amount of money spent on over-the-counter remedies for cough can be inferred to mirror the 
magnitude of the individual’s self perceived need for relief from the adverse affects of cough.  
Expenses for over-the-counter remedies purchased by those with cough are estimated to be in 
excess of several billion dollars annually (Altman & Irwin, 2010; Everett et al., 2007; Morice, 
2002).   
Definitions of chronic cough, and the duration of time for cough to be considered 
chronic, vary in the literature.  The definition of chronic cough used in this study is based upon 
symptom duration and it is that which has been proposed by the 2006 ACCP Guidelines (Irwin, 
Baumann, et al., 2006).  These guidelines propose three categories of cough, acute, subacute, and 
chronic, using duration of the symptom of cough to most efficiently work through the multitude 
of potential diagnoses most commonly associated with each category (Altman & Irwin, 2010; 
Irwin, Baumann, et al., 2006).  Acute cough, most likely being that which is related to the 
common cold, is described as having a duration of less than three weeks (Irwin, Baumann, et al., 
2006; Morice et al., 2007; Pratter, 2006a).  Subacute cough commonly occurs as part of the 
aftermath of an infection, such as cough secondary to an exacerbation of asthma due to the 
common cold, and is cough with a duration of 3 to 8 weeks (Irwin, Baumann, et al., 2006).  
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Chronic cough is defined as cough with a duration of greater than eight weeks that can be the 
result of any one or more of a wide variety of conditions (Irwin, Baumann, et al., 2006).   
The cause of chronic cough can most often be determined using the well established 
internationally recognized ACCP guidelines for the diagnosis and management of cough (Irwin, 
2010; Irwin, Baumann, et al., 2006).  These guidelines are meant to inform provider decisions 
regarding patient care through recommendations that have been graded by a consensus panel 
based upon both the quality of the evidence and the benefit/harm ratio to those with chronic 
cough (Irwin, Baumann, et al., 2006).  The ACCP guidelines use a systematic diagnostic 
protocol to identify the causes of cough and suggest empiric management interventions for the 
most common causes (Irwin, Baumann, et al., 2006).  
The ACCP guidelines provide algorithms for acute, subacute and chronic cough by which 
the cause(s) of cough can be identified and cause focused treatment interventions can be 
employed (Pratter, Brightling, Boulet, & Irwin, 2006).  See Figure 1.   
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Figure 1. Chronic cough algorithm for the management of patients > 15 years of age with 
cough lasting > 8 weeks.  ACE-I = ACE inhibitor, BD = bronchodilator, LTRA = 
leukotriene receptor antagonist, PPI = proton pump inhibitor.  Reproduced with 
permission from The American College of Chest Physicians from the “Diagnosis and 
Management of Cough Executive Summary, “ by  R.S. Irwin, M. H. Baumann, D.C. Bolser, 
L. P. Boulet, S.S. Braman, C.E. Brightling, et al., 2006, Chest, 129, p. 4S. Copyright 2006 by 
the American College of Chest Physicians.  
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The algorithm for chronic cough (see Figure 1) systematically directs the clinician to the 
assessment of the most common causes with the guidelines suggesting focused empiric treatment 
for each cause identified (Pratter et al., 2006).  If the initial chest radiograph is normal, or shows 
nothing more than stable inconsequential scarring, the patient is screened for exposure to 
environmental irritants such as cigarette smoking or use of an angiotensin converting enzyme 
inhibitor. After screening for and eliminating smoking and the use of angiotensin converting 
enzyme inhibitors, the management algorithm suggests initial empiric management interventions 
for the four most common causes of chronic cough: upper airway cough syndrome, asthma, non-
asthmatic eosinophilic bronchitis, and gastroesophageal reflux disease (Pratter et al., 2006).  If 
response to empiric intervention for the most common causes of chronic cough is inadequate the 
algorithm suggests further diagnostic and treatment interventions (Irwin, Baumann, et al., 2006).   
The ACCP guidelines note the importance of the systematic approach to diagnosis and 
management of chronic cough.  This approach is recognized as being important to sorting out the 
cause(s) of chronic cough, as often more than one cause is simultaneously in effect and the 
differential of potential diagnoses is extensive (Pratter et al., 2006). When the ACCP guidelines 
are employed with management interventions that are focused towards identifying and treating 
causes of chronic cough, success rates in managing chronic cough range from 54-100% (Irwin, 
Ownbey, Cagle, Baker, & Fraire, 2006; Pratter, 2006b, 2006c).  Reasons for this wide variability 
in reported success rates, in studies that employ cough guidelines for the management of chronic 
cough, are not clear.    
Initial management interventions for the four most common causes of chronic cough 
include the use of first generation antihistamine decongestants for upper airway cough 
syndrome; inhaled corticosteroids and bronchodilators and leukotriene receptor antagonists for 
asthma; inhaled corticosteroids for non-asthmatic eosinophic bronchitis, and the use of proton 
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pump inhibitors, diet and lifestyle changes, and on occasions, gastrointestinal prokinetic drugs 
for gastroesophageal reflux disease (Pratter et al., 2006).  Resolution of cough or self report of 
evident improvement is noted to signify successful treatment of chronic cough (Pratter et al., 
2006).   
While patients with chronic cough are sometimes diagnosed as having habit cough or 
psychogenic cough, these diagnoses are sometimes incorrectly used as a default when the cause 
of chronic cough cannot be explained (Irwin, Glomb, & Chang, 2006).  Cough management 
guidelines advise that the diagnosis of unexplained chronic cough only be used after failure of 
described diagnostic and treatment protocols with resulting reasoning that the cause of cough has 
not been successfully identified (Pratter, 2006c).   
Both subjective and objective outcome assessment measures can be used in the 
evaluation of chronic cough.  Subjective measures can include both visual analogue scales and 
cough-specific quality-of-life  questionnaires (Irwin, 2006a).  The Cough Quality of Life 
Questionnaire (subscale range Cronbach’s alpha .62-.86; and total scale .92) (C. T. French et al., 
2002) and the Leicester Cough Questionnaire (Cronbach’s alpha .79-.85 subscales and total scale 
.92) (S. S. Birring et al., 2003) are currently the most commonly used instruments to evaluate 
cough-specific quality-of-life in adults with chronic cough.  A variety of other single item 
numeric rating scales have been used to rate cough severity and/or frequency (Fletcher, French, 
Irwin, Corapi, & Norman, 2010; Smith, Owen, Earis, & Woodcock, 2006).  Objective measures 
that may be helpful in artificially stimulating cough in an effort to quantify cough reflex 
sensitivity include both the inhaled citric acid and capsaicin cough challenges (Irwin, 2006a; 
Wright, Jackson, Thompson, & Morice, 2010).  Computerized 24 hour cough counting has also 
been found to be useful for quantifying chronic cough (Irwin, 2006a).  
 10 
Symptom Qualities 
The symptom cough has been described as having different qualities.  Findings from a 
cross sectional qualitative study of three focus groups (N=22) resulted in the recommendation 
that chronic cough severity be evaluated in terms of the qualities of frequency, intensity and 
disruption (Vernon et al., 2009). Qualitative findings from the three focus groups identified 
words such as hacking, deep, strong, harsh, intense, and barking used to describe the intensity of 
chronic cough (Vernon et al., 2009).  With regards to frequency, participants noted that cough 
could be continuous or intermittent and their personal awareness of the cough could vary in that 
at times they were not aware of the symptom (Vernon et al., 2009).  Additional findings from 
this study included chronic cough occurring during daytime activities or nighttime sleep as being 
disruptive to the life of those studied (Vernon et al., 2009).   
Symptom Combinations 
Multiple symptom combinations have been reported in association with chronic cough.  
Prospective questionnaire interviews in patients (N=108) seeking medical attention for chronic 
cough followed by thematic reduction of data resulted in identification of 18 reasons for seeking 
assistance (Irwin & Curley, 1991).  Physical issues identified included exhaustion (57%), 
musculoskeletal pain (44%), hoarseness (43%), excessive perspiration (42%), urinary 
incontinence (39%), dizziness (38%), headache (32%), retching (21%), vomiting (18%), nausea 
(16%), anorexia (15%), and syncope (5%) (Irwin & Curley, 1991).  Sleep disturbances 
associated with chronic cough were reported as insomnia (45%) (Irwin & Curley, 1991).  In a 
similar study (N=136), symptoms associated with cough were noted to be a minor to major 
problem and included exhaustion (66%), fainting (16%), and sleep disturbances (78%) (Kuzniar 
et al., 2007).  Postal survey results (N=856) seeking information related to chronic cough in the 
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United Kingdom found that in those who returned the survey (N=373) a number of  physical 
complaints were reported and included breathlessness (55%), wheeze (37%), tired (72%), sore 
throat (45%), incontinence (55% in females, 5% in males), syncope (10%) dizziness (20%), and 
disturbed sleep (70%) (Everett et al., 2007).  Qualitative focus groups have noted sleep 
disruption as a problem for those with chronic cough (Vernon et al., 2009).   
Cross sectional descriptive studies have identified urinary incontinence to be an 
important reason for seeking medical attention for chronic cough N =108, 39% (Irwin & Curley, 
1991);  N=136, 43% (Kuzniar et al., 2007).  In a study of gender differences (N=154; n=116, 
female 38 male) using a 28 item cough-specific quality-of-life questionnaire woman scored 
significantly higher than men on only one item and that item was urinary incontinence t(29) = -
2.48; p =.021 (C. T. French, Fletcher, & Irwin, 2004).   
Physiologic Factors 
Cough Anatomy and Physiology 
Cough is a visceral reflex (Canning, 2006, 2007) that results in a respiratory maneuver 
involving inspiration, followed by expiration against a closed glottis that then opens allowing an 
expulsion of air producing the characteristic sound recognized as cough (McCool, 2006).  The 
cough reflex is thought to be regulated by mechanisms that are both non voluntary and voluntary 
(Canning, 2007).  Stimuli for cough can include inhalation of some type of matter, inflammation 
and inflammatory mediators originating in the airway and mechanical stimuli from extra 
pulmonary sources such as the ear and esophagus (Canning, 2006).   
The cough reflex is initiated with the afferent neural pathways bringing the cough 
stimulus to the central nervous system and efferent pathways responsible for respiratory muscle 
action that are involved in cough (Canning, 2006).  It has been proposed that cough is generated 
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via these afferent vagal neural pathways, bringing the stimulus for cough to the brain stem and 
cerebral cortex, with the spinal cord also playing a role in the process (Canning, Mori, & 
Mazzone, 2006; Mazzone, 2004).  Efferent impulses are then generated from the brain stem and 
cerebral cortex resulting in the respiratory muscular effort producing cough (Canning, 2006; 
Mazzone, 2004).  Cognition and conscious action are thought to potentially play some role in the 
voluntary generation of cough at the level of the cerebral cortex (Davenport, 2009).   
Urge-to-Cough 
The urge-to-cough has been described as a respiratory sensation that precedes cough 
(Davenport, Vovk, Duke, Bolser, & Robertson, 2009).  The urge-to-cough is thought to be the 
result of the translation of stimuli to neural responses that are interpreted and responded to at the 
level of the cerebral cortex by the motor action of cough (Davenport, 2009; Mazzone, 2004).  
Additionally, urge-to-cough describes an internal signal that may be related in the clinical 
situation as a sensation in the throat or lungs that is perceived as the need to cough, resulting in 
the physical action of cough (Woodcock, Young, & Smith, 2010).  Qualitative focus groups have 
identified patients as relating a tickle in the throat that ultimately leads to cough (Vernon et al., 
2009).   
It has been proposed that some voluntary control of cough is possibly related to the 
translation of the urge-to-cough to the motor action of cough (Canning, 2007).  In a study 
evaluating urge-to-cough and cough motor response modulation by the central effects of 
nicotine, 20 smoking and non smoking subjects rated their urge-to-cough or intensity of their 
need to cough after nicotine administration (Davenport et al., 2009).  In this study urge-to-cough 
scores were significantly lower (p<.05) in smokers at higher concentrations of capsaicin after 
nicotine administration (Davenport et al., 2009).  Results of this study suggest that central neural 
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response to nicotine is associated with a modulation of perceptual and motor cough response to a 
known cough stimulus (Davenport et al., 2009).  In an effort to evaluate the usefulness of 
mindfulness stress reduction training as an intervention used in an effort to reduce urge-to-cough 
on inhaling citric acid and to reduce cough and cough reflex sensitivity, two sequential trials 
were conducted (Young et al., 2009).  The trials included one with healthy subjects (N=30) and 
one with those with chronic cough (N=30) and each trial randomized subjects to no intervention, 
mindfulness, and to voluntary cough suppression (Young et al., 2009).  Mindfulness reduced 
cough sensitivity in healthy controls (p=0.043) but not in those with chronic cough; both groups 
were able to voluntarily suppress cough in response to citric acid inhalation (healthy p=0.002; 
cough p=0.02), and there were no significant changes in urge-to-cough (Young et al., 2009).   
Medical Conditions Causing Cough 
Chronic cough can be a symptom resulting from one or more condition(s) (Pratter, 
2006b).  It is widely accepted that the most common causes of chronic cough include upper 
airway cough syndrome, asthma, non-asthmatic eosinophilic bronchitis, and gastroesophageal 
reflux disease (Irwin, Baumann, et al., 2006; Pratter, 2006b).  These most common causes, along 
with cigarette smoking and use of angiotensin converting enzyme medications, explain the 
greatest majority of cases of chronic cough (Pratter, 2006b).  A wide range of other causes are 
responsible for 6 percent or less of chronic cough (Madison & Irwin, 2010).  Conditions of 
varying severity such as bronchogenic carcinoma, bronchiectasis, pharyngeal dysfunction, 
interstitial lung disease, heart failure, tuberculosis, and psychogenic issues are some of the other 
causes of chronic cough (Madison & Irwin, 2010).  In at least twenty five percent of cases, more 
than one cause of chronic cough can concurrently be identified (Irwin, Curley, & French, 1990).  
It can be inferred that treatment complexity increases for both the patient and the provider when 
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more than one diagnosis is concurrently in operation.  It can also be inferred that when treatment 
complexity increases adherence to treatment may be more difficult to achieve. 
Physical Complications of Cough 
Chronic cough can also result in the development of a multitude of physical 
complications resulting in secondary diagnoses (Irwin, 2006b).  The physical trauma from the 
physical action of cough can induce an inflammatory state in the airways (Irwin, Ownbey, et al., 
2006).  Complications of cough can vary in severity affecting multiple body systems including 
cardiovascular, gastrointestinal, genitourinary, musculoskeletal, neurological, ophthalmologic, 
and integumentary systems (Irwin, 2006b).  Complications resulting from cough can be those 
that are bothersome, but not life threatening, such as subconjunctival hemorrhage or urinary 
incontinence (Irwin, 2006b).  In contrast, case reports of complications of cough include those 
that  can be potentially life threatening such as diaphragmatic rupture (Chaar, Attanasio, & 
Detterbeck, 2008; Daniel, Naidu, & Khalil-Marzouk, 2008; Kallay et al., 2000), the development 
of stress cardiomyopathy (Butman, 2010; Dahdouh et al., 2011), and myocardial infarction 
(Butman, 2010).  Chronic cough, thought to occur as a manifestation of pulmonary infection or 
inflammation, has been reported in association with an overall increase for myocardial infarction 
(non productive chronic cough OR 1.8; 95% CI 1.1-2.8 and productive chronic cough OR 1.6; 
95% CI 1.1-2.4) (Haider et al., 1999). 
Cough Related Problems with Speaking 
Cough related problems with speaking have been noted in multiple descriptive cross 
sectional studies of those with chronic cough (Everett et al., 2007; C. T. French et al., 2004; 
Kuzniar et al., 2007).  One study of those with chronic cough (N=53) reported speaking as a 
trigger for cough in 71% of participants (Vertigan & Gibson, 2011).  Problems with speaking 
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that have been identified include: cough affecting the voice 67% (Everett et al., 2007), 
hoarseness 43% (Irwin & Curley, 1991), 53% (Kuzniar et al., 2007) and trouble speaking 63% 
(Kuzniar et al., 2007).  Impairment in vocal quality has been described as a problem in as many 
as 40% of those with chronic cough (Gibson & Vertigan, 2009).  In a study of cough triggers in 
those with chronic cough unresponsive to medical management (N=53), triggers that are not 
known to stimulate cough receptors included abnormal sensation in the throat (85%), talking 
(71%), and talking on the telephone (56%) (Vertigan & Gibson, 2011).  Qualitative focus groups 
specifically identified coughing as affecting voice quality while speaking (Vernon et al., 2009) 
Psychologic Factors 
Depression and Anxiety in the General Population 
Based upon the frequency of anxiety and depression in the population at large, it stands to 
reason that many of those who are seeking care for chronic cough may concurrently suffer from 
one or both of these problems with its associated manifestations.  Depression is differentiated 
from anxiety in that it is one of multiple mood disorders and a disorder characterized by extreme 
and sustained sadness (American Psychological Association, 2010b; Task Force on DSM-IV, 
2000).  DSM-IV criteria for a Major Depressive Disorder,  that has a lifetime risk of 10-25% in 
females and 5-12% for males in community samples, include the presence of one or more Major 
Depressive Episodes (Task Force on DSM-IV, 2000).  A Major Depressive Episode is 
characterized by at least two weeks of depressed mood or loss of interest accompanied by at least 
four other specified symptoms that may include psychomotor agitation or retardation or fatigue 
and is also associated with impairment in usual life activities (Task Force on DSM-IV, 2000).  
Major Depressive Disorder needs to be differentiated from issues associated with normal life loss 
and from Mood Disorder Due to a General Medical Condition (Task Force on DSM-IV, 2000).  
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Similar to Generalized Anxiety Disorder, Mood Disorder Due to a General Medical Condition is 
that in which the physiologic consequences of a medical condition are felt to be the cause of  the 
symptoms (Task Force on DSM-IV, 2000). For the purposes of this study, depression was 
defined as a state characterized by symptoms of dysphoria, hopelessness, devaluation of life, 
self-depreciation, lack of interest or involvement, anhedonia, and inertia (P. F. Lovibond & S. H. 
Lovibond, 1995). 
While there are a number of major anxiety disorders, anxiety is identified in general as a 
psychologic condition characterized by the symptoms of excessive and sustained fear and worry 
(American Psychological Association, 2010a).  Generalized Anxiety Disorder, one of the more 
common anxiety disorders with a reported lifetime prevalence of 5% in a community sample, is 
that where symptoms occur on more days than not and are sustained over a period of at least 6 
months (Task Force on DSM-IV, 2000).  To meet the criteria established by the Diagnostic and 
Statistical Manual of Mental Disorders – IV  (DSM-IV) of a Generalized Anxiety Disorder, the 
fear and worry described must also be accompanied 3 or more other specific symptoms such as 
restlessness, irritability, and muscle tension (Task Force on DSM-IV, 2000).  Generalized 
Anxiety disorder is differentiated from Anxiety Disorder Due to a General Medical Condition 
when the physiologic consequences of a medical condition are felt to be the cause of  the 
symptoms (Task Force on DSM-IV, 2000).  Generalized Anxiety Disorder is also to be 
differentiated form Somatoform Disorders where anxiety and worry are associated with physical 
symptoms that could suggest a medical problem but are not fully explained by the medical 
problem (Task Force on DSM-IV, 2000).  For the purposes of this paper, anxiety was defined as 
a state characterized by symptoms of autonomic arousal, skeletal muscle effects, situational 
anxiety, and subjective experience of anxious effect (P. F. Lovibond & S. H. Lovibond, 1995).   
 17 
The term stress as used in this study refers to a state of nervous tension characterized by 
symptoms of difficulty relaxing, nervous arousal, being easily upset or agitated, irritable or 
overreactive and impatience (P. F. Lovibond & S. H. Lovibond, 1995).   This definition of stress 
has been proposed as being akin to the state of Generalized Anxiety Disorder (Lovibond, 1998). 
While anxiety and depression exist as separate and distinct conditions, they also share a 
component of general affective distress and a potential overlap in symptomatology such as 
occurs with restlessness, fatigue, problems with concentration, and insomnia (Clark & Watson, 
1991; Task Force on DSM-IV, 2000).  Mixed Anxiety-Depressive Disorder has been identified 
as having a primary care prevalence rate of 1.3 - 2% and is a description used to identify a 
clinically significant combination of the symptoms described and more in association with a 
persistent dysphoric mood of at least one months’ duration (Task Force on DSM-IV, 2000).  
While research criteria for establishing the presence of Mixed Anxiety-Depressive Disorder are 
defined, individuals who meet the criteria are formally identified using a DSM-IV diagnosis of 
Anxiety Disorder Not Otherwise Specified (Task Force on DSM-IV, 2000).  Additionally, 
depression and anxiety have been related to elevated levels of the pro-inflammatory marker 
pleiotropic cytokine interleukin-6 (Morozink, Friedman, Coe, & Ryff, 2010) opening speculation 
as to their role in chronic cough. 
Depression and Anxiety and Chronic Cough in the General Population 
 The symptom chronic cough has been reported in association with multiple psychologic 
factors such as depression, anxiety, and stress.  Epidemiologic population cohort studies have 
associated the presence of depression and anxiety or their symptomatology with chronic cough 
(Adams, Appleton, Wilson, Taylor, & Ruffin, 2009; Dales et al., 1989).  An Australian adult 
longitudinal population cohort of those without identified lung disease (n=3,355) found 18.2% of 
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those studied at baseline to complain of chronic cough (Adams et al., 2009).   Using the General 
Health Questionnaire (CHQ)-28 anxiety and depression domains in the same (n=3,355) 
population, 23.6% were classified as having anxiety and insomnia and 34.4% severe depression 
(Adams et al., 2009).  In this study, overall severe and mild GHQ-28 scores in those who were 
complaining of chronic cough at baseline improved when cough was reported as resolved (24.8% 
to 16.9%; p<0.01 vs. never coughed) (Adams et al., 2009). Secondary analyses of a Canadian 
population cohort of never smokers, with no reported respiratory disease and normal spirometry 
(n=600; age 14-55; 63% female, 37% male) were derived from a large (N=3,628) population 
based health survey (Dales et al., 1989).  Using the Psychiatric Symptom Index (PSI) and the 
American Thoracic Society Respiratory Symptom Questionnaire, associations were found 
between chronic cough and PSI subscales (anxiety symptoms OR 1.64; 95% CI 1.16-2.30; p 
<0.05; depression symptoms OR 1.39; 95% CI 1.06-1.82; p <0.05) (Dales et al., 1989).    
Psychologic Complaints in Chronic Cough 
Multiple cross sectional descriptive studies have identified psychological complaints as 
being related to chronic cough.  Psychologic complaints identified (N=108) in a study of reasons 
patients seek medical attention for chronic cough were reported as including issues such as 
feeling that something is wrong (98%), self-consciousness (55%), fear of cancer (33%), fear of 
AIDS or tuberculosis (28%) (Irwin & Curley, 1991).   A questionnaire included in a packet 
mailed to individuals requesting chronic cough information offered during a radio broadcast was 
returned by 43%  (N = 856; n = 373) of those surveyed (Everett et al., 2007).  Respondents 
reported multiple psychologic complaints and were characterized as follows: (n=373; M = 65.3, 
SD=12) years of age; 73% female; 41% ex-smokers; 8% current smokers; median duration of 
cough 6.5 years; 66% no prior respiratory disease).  Psychological findings included anger or 
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frustration (83%), not feeling in control of their body (76%), worry about health (69%), 
depressed (55%), upset (80%) and worried about what others think (76%) secondary to chronic 
cough (Everett et al., 2007).  Similarly, in a study of those seeking medical assistance for cough 
(N=136),  patient complaints included feeling frustrated, irritable or angry (79%) and anxiety 
about an underlying problem (66%) (Kuzniar et al., 2007).  A focus group study of participants 
with chronic cough (N=22) related feelings of being annoyed, frustrated, irritated and worried 
because of cough (Vernon et al., 2009).   
Anxiety in Chronic Cough 
Multiple studies have noted the presence of anxiety in those with chronic cough.  The 
prevalence of  psychologic factors associated with chronic cough was explored in patients 
without prior psychiatric disease (McGarvey et al., 2006).  In this study, a single visit survey 
(N=57; n=47 female; M = 47.5 (14.3) years of age; cough duration M=69.2 (78.5) months) 
identified subgroups of those with explained (n=42) and unexplained chronic cough (n=15) 
(McGarvey et al., 2006).   With patients being matched for cough severity by use of a visual 
analogue scale, State Trait Anxiety Inventory scores identified 72% of patients as having low 
state anxiety and 28% as having moderate state anxiety (McGarvey et al., 2006). Trait anxiety 
levels were identified as moderate in 44.2% and high in 3.8% of patients (McGarvey et al., 
2006).   Scores using the Hospital Anxiety and Depression Scale identified 21% of all patients as 
having borderline anxiety and 12.3% as having clinically important anxiety symptoms 
(McGarvey et al., 2006).  Independent t-test comparing the means of all those with cough to 
healthy populations (M=32.8, SD =8.3) found Trait anxiety to be significantly higher among 
those with cough (M = 38.9, SD = 11.3; p<.001).  Significantly higher scores (N=57) were found 
for phobic anxiety (t = 2.32; p<.05), obsession (t = 1.71; p<.05), and somatization (t =3.9; 
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p<.001) (McGarvey et al., 2006).  Trait anxiety was significantly higher in treatment non-
responders compared to treatment responders (M=36.3, SD=9.53 vs. M=30.92, SD=8.20; p = 
0.027). 
In an effort to determine whether affective state driven by the withdrawal of the 
anxiolytic nicotine would modulate cough in 20 smoking adults and matched controls, subjects 
inhaled capsaicin before and after nicotine or placebo gum (Davenport et al., 2009).  Withdrawal 
from smoking for 12 hours in smoking subjects resulted in an increase in urge-to-cough ratings, 
number of coughs, and trait anxiety scores while administration of nicotine gum resulted in a 
reduction in the same measures and the placebo gum had no effect (Davenport et al., 2009).  In 
the smokers, nicotine gum decreased trait anxiety scores measured using the State Trait 
Inventory (M=36.3+3 to 34.3+3; p=.03) (Davenport et al., 2009).   
In an effort to evaluate mindfulness, stress reduction training as an intervention for 
chronic cough, healthy subjects (N=30) were compared to those with chronic cough (N=30) and 
each subject was randomized  to receive no intervention, mindfulness, or to voluntary cough 
suppression (Young et al., 2009).  Anxiety was measured in this study using the State Trait 
Anxiety Inventory. No significant change was found post intervention in either state (p=0.23) or 
trait anxiety (p=0.78) for either group (Young et al., 2009).  Those with chronic cough, in 
comparison to a working population, were found to have high trait anxiety levels (males 
M=36.60, SD=16.21 vs. M=34.89, SD=9.19 and females M=40.50, SD=11.00 vs. M=34.79, 
SD=9.22) but below average state anxiety scores (M=30.50, SD=10.30 vs. M=35.72, SD=10.40 
and females M=34.15, SD=8.83 vs. M=35.20, SD=10.61) (Young et al., 2009).   
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Depression in Chronic Cough 
Several studies have assessed the presence of depression in chronic cough.  The Hospital 
Anxiety and Depression Scale was used to identify depression in those with chronic cough 
(N=57) finding 10.5% as having borderline depressive symptoms and 5.3% as having clinically 
important depression symptoms (48%) (McGarvey et al., 2006).  Significantly higher depression 
scores were found in those with chronic cough (t =2.54; p<.05) compared to published healthy 
controls (McGarvey et al., 2006).  The prevalence of depressive symptoms among patients with 
chronic cough was also investigated using a non-randomized prospective intervention trial 
(Dicpinigaitis et al., 2006). At baseline (N = 100), 53% scored positively for significant 
depressive symptomatology and risk for depression (CES-D M = 18.3, SD =13.2) (Dicpinigaitis 
et al., 2006).  Both cough and depression scores significantly improved in those who completed 
the post intervention testing (n=81; CES-D; M = 7.4, SD=10.4); cough z = 7.34; Wilcoxon 
signed –ranks test p<.001; and depression z = 7.14; Wilcoxon signed-ranks test; p<.001 ) 
(Dicpinigaitis et al., 2006).  Findings also included improvement in cough and depression as 
being moderately correlated (r =.323; p =.003) (Dicpinigaitis et al., 2006).  
Stress in Chronic Cough 
Stress has also been reported in association with chronic cough.  In young healthy 
individuals (N=47), greater numbers of common health complaints including cough have been 
reported (Lovell, Moss, & Wetherell, 2011).  In this study, those with higher levels of self 
perceived stress were found to have hypersecretion of cortisol when compared to those with 
lower levels of stress (Lovell et al., 2011).  In a study of bank call center workers (N=289) in 
Taiwan, multivariate logistic regression demonstrated that when compared to those reporting low 
stress, workers reporting high stress had significantly greater complaints of chronic cough with 
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phlegm (OR=2.13, 95% CI = 1.02-4.44) (Lin et al., 2010).  This study was limited in that 
smoking status of the subjects was not reported (Lin et al., 2010).   
In a study of cough triggers in those with chronic cough unresponsive to medical 
management (N=53), reports of stress as a trigger were compared with Hospital Anxiety and 
Depression Scale (HADS) scores (Vertigan & Gibson, 2011). Subjects reporting stress had 
higher anxiety and depression scores (anxiety p=0.002; depression p= 0.020) than those not 
reporting stress; yet, all scores were in the normal range (Vertigan & Gibson, 2011).  Anxiety 
and depression scores were similar in this study when comparing those reporting stress as a 
trigger for cough to those who did not report stress as a trigger (M=8.6, SD=4.1); vs. M=8.1, 
SD=2.9) and no significant correlations were found between urge-to-cough and either anxiety 
(r=0.036, p=.0.780) or depression (r=0.019, p=0.881) (Vertigan & Gibson, 2011).   
Situational Factors 
Demographic Variables 
Situational factors such as gender, age, work, ability to socialize in public situations, time 
of day, and number of physician visits have been reported in association with chronic cough.  
Gender has been identified as an issue in chronic cough with more woman seeking assistance for 
chronic cough than men (C. T. French et al., 2004; Kelsall, Decalmer, McGuinness, Woodcock, 
& Smith, 2009).  Additionally, the cough reflex has been found to be more sensitive to 
provocative challenge in woman using both capsaicin (p = 0.0007) and citric acid (p=0.032) 
when compared to men (Kastelik et al., 2002).  In a study of sex differences and predictors of 
objective cough frequency (N=100; n =65 females, n=35 males), woman coughed more than 
men (M=16.6 vs. 9.5; p=0.01).  Linear regression showed 38.6% of the variation in cough 
frequency was predicted by sex (p=0.01) and age (p<0.001) (Kelsall et al., 2009).  In a study of 
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gender differences in health related quality-of-life in patients complaining of chronic cough, 
women reported more adversely affected cough-specific quality-of-life  when compared to men 
(n=116 female; n=38 male; M= 67.1 vs. 59.7; p =0.002).  In the same study, it was noted that 
men and women scored differently in the various subscales with urinary incontinence being 
greater in women and the item demonstrating the most significant difference (p<0.001) (C. T. 
French et al., 2004). 
A prospective self report survey (N=146, n=136) used to identify factors that patients 
identify as a major problem secondary to cough include lifestyle/leisure (38%), frequent 
physician visit/testing (41%), interference with social gatherings (35%),  other peoples’ reactions 
(32%), expense for medications (21%), spouse moving out of the bedroom (13%), and being 
absent from work (11%) (Kuzniar et al., 2007).   A questionnaire mailed to those requesting 
information (N=853; n=373 returned) offered during a radio broadcast revealed  multiple 
negative affects related to chronic cough (Everett et al., 2007).  Negative effects reported in this 
study, as related to chronic cough, included altering behaviors involving cinema or bingo (39%), 
eating out (34%), visiting family and friends (19%), affecting phone calls (81%) and hobbies 
(45%) (Everett et al., 2007).  While only 45% of those responding were employed, 53% noted 
that cough affected their employment (Everett et al., 2007).  
Focus groups have been used to assess the severity of chronic cough from the participants 
perspective (Vernon et al., 2009).  Participants in three focus groups (N = 22) composed of those 
with chronic cough identified the adverse impact of chronic cough as related to situations 
specific to work, ability to socialize in public, and sleep (Vernon et al., 2009).    
Qualitative review of videos of those seeking assistance for cough (N=33) using 
sociolinguistic analysis put cough in the perspective of a non-verbal behavior involved in the 
process of complex communication between the patient and physician (Bailey, 2008). This 
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analysis was described as based upon language that is dependent upon the social context and the 
concepts of social accountability and maintenance of face (Bailey, 2008).  Cough was found to 
be dependent upon the social situation rather than cough as a direct physical complaint (Bailey, 
2008).  Cough was noted to be used by the patient to animate symptoms during explanation to 
further elucidate a problem when the patient and the general practitioner did not agree on the 
importance of what was being presented by the patient (Bailey, 2008). Cough was proposed as a 
communicative resource, a non verbal behavior used in physician patient communication as well 
as a manifestation of respiratory disease (Bailey, 2008).  Similarly, qualitative interviews (N=30) 
revealed that those who perceived cough as abnormal, causing worry, and interfering with social 
roles were more likely to seek medical assistance (Cornford, 1998).   
Social Support 
Definitions of social support vary, yet it is generally accepted that greater levels of social 
support are associated with better physical and psychological health (Broadhead et al., 1983; 
Powers, Goodger, & Byles, 2004).  Social support, a concept with many definitions (Finfgeld-
Connett, 2005; Langford, Bowsher, Maloney, & Lillis, 1997; Williams, Barclay, & Schmied, 
2004),  can be viewed as a buffer of the effects of stress on psychologic and physical health, or 
as a determinate or outcome of health (Broadhead et al., 1983).  It has been proposed that high 
levels of social support are important to psychologic health and that the impact of stress has 
greater adverse effects when social support is low (Broadhead et al., 1983; Landerman, George, 
Campbell, & Blazer, 1989).  
Social support can be defined as a multidimensional construct composed of the social 
network, social interactions, self perceived or subjective social support, and instrumental or 
tangible service support (George, Blazer, Hughes, & Fowler, 1989; Landerman et al., 1989).  
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Social support can also refer to social transactions such as a confident relationship where 
important issues are shared, affective support or positive emotional expression, affirmation or 
expressions of agreement or praise, and/or aid or direct tangible cognitive or physical assistance 
(Broadhead et al., 1988; Broadhead et al., 1983).  The term instrumental support or aid has been 
used to describe a dimension of social support that is more specific to those in need of support 
from outside the home and is not necessarily related to populations that are not in need of outside 
services (Koenig et al., 1993).     
Social support can be measured by evaluating the qualitative or functional aspects of 
supportive relationships and/or by the quantitative or structural aspects of supportive 
relationships such as size of the social network (Broadhead et al., 1989; Broadhead et al., 1988).  
Qualitative aspects of supportive relationships can include emotional, appraisal, informational, 
and instrumental dimensions of support (Broadhead et al., 1989).  In contrast, quantitative 
support relates to issues such as size and frequency of social networks (Broadhead et al., 1989).  
When assessing the impact of social support on health outcomes, qualitative or functional 
dimensions of social support rather than the quantitative dimensions have been identified as 
being most important (Broadhead et al., 1988; Broadhead et al., 1983).  Emotional support, as an 
aspect of the qualitative or functional aspects of social support, has been cited as the most 
important predictor of the impact of social support on health outcomes (Broadhead et al., 1989; 
Broadhead et al., 1988).  This study will limit its focus to the dimensions of social support 
related to relationships where important issues are shared and support related self perceive 
positive emotional expression from others (Broadhead et al., 1989; Broadhead et al., 1988) 
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Performance and Consequences 
Health Related and Cough-Specific Quality-of-Life  
Health related quality-of-life refers to a construct that includes subjective collective 
evaluations of multiple domains representing aspects of life whose quality may be impacted  by 
health issues such the symptom experience (Centers for Disease Control and Prevention, 2011; 
U.S. Department of Health and Human Service, 2010).   Domains identified as part of health 
related quality-of-life vary, most often including mental, physical, and social functions (U.S. 
Department of Health and Human Service, 2010), as well as occupational and somatic sensations 
(Schipper, Clinch, & Olweny, 1996).  The patient’s perception of symptoms, the way they affect 
individual ability to function, and the way the resulting distress from symptoms is communicated 
have been cited as contributing to the overall illness experience (Schipper et al., 1996).  It has 
also been noted that physiological and psychological states are often interdependent as 
demonstrated by the case of stress and hypertension (Schipper et al., 1996). The measurement of 
health related quality-of-life can be important in understanding the burden of disease and 
progress towards reducing this burden (Centers for Disease Control and Prevention, 2011).    
Cough-specific quality-of-life is a useful outcome measure for identifying the impact of 
chronic cough on patients’ lives and for assessing response to treatment (S. S. Birring et al., 
2003; C. T. French et al., 2002).  Chronic cough has been described as having a negative effect 
on overall and on the physical, psychological, and social domains of quality-of-life (S. S. Birring 
et al., 2003; C. T. French et al., 2002).  In a study of patients presenting to an adult respiratory 
clinic for treatment of cough, those successfully treated (N=9) have reported overall 
improvements in the individual domains of cough-specific quality-of-life  (S. Birring et al., 
2007).  Improvements in all domains of quality-of-life measured in this study included: physical 
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(effect size 1.00), psychological (effect size 1.75), and social (effect size 0.84) domains (S. 
Birring et al., 2007).  Similarly, in a study of those presenting to a cough specialty clinic, 
successfully treated patients (N=24) reported significant improvements (p< 0.001) in mean score 
for each domain of cough-specific quality-of-life  (C. T. French et al., 2002).  Domains measured 
included physical complaints M= 63.33, SD=13.69 to M=30.50, SD=5.80, psychosocial issues 
M=21.19, SD=5.75 to M= 9.67, SD=1.97, functional abilities M=13.79, SD=3.48 to M=5.54, 
SD=1.28, emotional well-being M=7.59, SD=1.69 to M=3.54, SD=1.18, extreme physical 
complaints M=8.13, SD=2.77 to M=4.29, SD=0.91, and personal safety fears M=6.38, SD=2.12 
to M=4.21, SD=0.83 (C. T. French et al., 2002). 
Adverse effects on total quality-of-life scores (N=9; t-test not reported; p<.007; N=24; t=-
10.73; p < .001) have significantly improved with successful treatment of chronic cough (S. S. 
Birring et al., 2003; C. T. French et al., 2002).  Additionally, multiple studies have noted 
interference with lifestyle as a problem for those with chronic cough (N =373, 64%; N =108, 
45%; N =136, 81%) (Everett et al., 2007; Irwin & Curley, 1991; Kuzniar et al., 2007).  The 
burden of chronic cough on patients can be inferred based upon data that demonstrate that the 
health related quality-of-life scores in patients with chronic cough are of similar severity when 
compared to those of patients with severe disabling dyspnea due to chronic obstructive 
pulmonary disease (C. L. French, Irwin, Curley, & Krikorian, 1998).   
Intervention Fidelity and the Reliability and Validity of Study Outcomes 
Intervention Fidelity 
While intervention fidelity measures that specifically address the adherent and competent 
delivery of proposed management interventions by the interventionist (Santacroce et al., 2004) 
appear to be important, intervention fidelity has not been reported in studies of chronic cough.  
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Intervention fidelity is important to ensuring the reliability and validity of an intervention’s 
effects on the outcomes (Bellg et al., 2004; Santacroce et al., 2004).  The lack of clearly 
identified intervention fidelity measures has resulted in difficulty in assessing reliability and 
validity issues that may play a role in variations in outcomes of studies using specified 
management strategies (Bellg et al., 2004; Santacroce et al., 2004).  The Technology Model for 
ensuring intervention fidelity that focuses on the use of a manual, training and supervision of 
those who deliver the intervention, and monitoring of the processes has been found to be useful 
in research (Santacroce et al., 2004).  Measuring subject receipt of information is an additional 
component of intervention fidelity that has been shown to be important in reducing statistical 
error and therefore unexplained variation when formulating study conclusions (Santacroce et al., 
2004).  Use of the Technology Model for managing and monitoring intervention fidelity was 
important to the reliability and both the internal and external validity of the conclusions of this 
study. 
Summary 
 
A focused review of the literature in the area of research associated with the impact of 
chronic cough on patients and the concurrent presence of psychologic factors has been provided.  
This review has demonstrated support for the serious impact of the symptom as experienced by 
patient with chronic cough.  This review also demonstrates the concurrent presence of 
psychologic factors such as the symptoms of depression, anxiety, and stress in those with chronic 
cough.  Social support has been cited as being associated with better physical and psychological 
health.  Intervention fidelity has been shown to be important to the reliability and validity of 
research findings. 
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The strength of the evidence supporting the presence of the symptoms associated with the 
psychologic factors of depression, anxiety, and stress in those with chronic cough vary.  No 
study could be found that directly assesses social support or intervention fidelity in those with 
chronic cough.  Epidemiologic studies provide evidence for an association of the psychologic 
factors of depression, anxiety, and stress with chronic cough in the population at large.  
Qualitative, descriptive, and quasi-experimental studies provide evidence for the association of 
these psychologic factors in those seeking medical care for chronic cough.  The strength of the 
evidence related to the psychologic factors associated with chronic cough severity and 
performance outcomes has been limited by studies that are primarily descriptive and cross 
sectional, use of small size samples, and by study designs that are not randomized, controlled, 
and interventional.  No studies were identified that concurrently assess longitudinal changes in 
the symptoms of depression, anxiety, and stress in those whose chronic cough is both defined 
and treated based upon the diagnostic and management interventions recommended by the 
ACCP guidelines.   
This study provides information related to longitudinal changes in symptoms of 
depression, anxiety, and stress in those with chronic cough treated using the ACCP guidelines.  
Additionally, this study provides information regarding the longitudinal influence of 
psychologic, physiologic factors, and the situational factor of social support associated with 
chronic cough.  Finally, a process for measuring intervention fidelity in the application of the 
ACCP guidelines has been described. 
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CHAPTER 2 
 Theoretical Framework 
The purpose of this prospective study was to describe changes in the psychologic 
symptoms of depression, anxiety, and stress in adults with chronic cough after standardized 
management intervention using the ACCP guidelines.  Additionally, this study describes the 
influence of physiologic factors (ability to speak without coughing, urge-to-cough, and number 
of diagnoses), situational factors (social support), and psychologic factors (symptoms of 
depression, anxiety, and stress) on cough severity (timing, distress, intensity, and quality) and 
cough-specific quality-of-life following standardized treatment.  The Theory of Unpleasant 
Symptoms (Lenz et al., 1997) was  used as a guide to assess and describe the concepts addressed 
in this study.     
Theory Overview 
The Theory of Unpleasant Symptoms, first described in 1995 by Lenz, Suppe, Gift, Pugh, 
and Milligan, was proposed as a middle range theory developed to help guide research and 
practice in the area of symptoms across multiple populations (Lenz, Suppe, Gift, Pugh, & 
Milligan, 1995).  This theory was devised in an effort to improve the understanding of the 
experience of a symptom and to provide information that would be helpful in identifying 
preventive and/or management interventions for patients experiencing the adverse impact of 
symptoms (Lenz & Pugh, 2008; Lenz et al., 1997; Lenz et al., 1995).  The theory was revised in 
1997 in response to further recognition of the complexity and interactive nature of the patient 
experience of one or more simultaneously experienced symptoms (Lenz & Pugh, 2008; Lenz et 
al., 1997).  The theory implies that managing one symptom contributes to the management of 
others (A. Gift, 2009).  See Figure 2.   
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Figure 2.  Schematic representation of the Theory of Unpleasant Symptoms.  Reproduced 
with the permission of Wolters Kluwer Health from “The Middle-Range Theory of 
unpleasant symptoms: An update,” by E.R Lenz, L.C. Pugh, R.A. Milligan, A. Gift, and F 
Suppe, (1997), Advances in Nursing Science, 19, p. 14-27. Copyright 2008 by Aspen 
Publishers, Incorporated.  See text for an in-depth description of how each component of 
this figure relate to each other and the theory. 
Assumptions and Antecedents of the Theory 
According to Lenz and colleagues (1997), the Theory of Unpleasant Symptoms includes 
the following assumptions: 
a) Symptoms are multidimensional and include: timing, intensity, quality, and distress 
(Lenz et al., 1997); 
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b) Symptoms are experienced alone or more commonly in combination with other 
symptoms (Lenz et al., 1997) and the relationship is multiplicative rather than 
additive (A. Gift, 2009); 
c) The simultaneous presence of more than one symptom results in each symptom 
catalyzing the other (Lenz et al., 1997); 
d) Physiologic, psychologic, and situational factors, all of which can interact with one 
another, influence the multidimensional symptom(s) experience (Lenz et al., 1997); 
e) Consequences of the symptom experience include both functional and cognitive 
performance (Lenz et al., 1997); 
f) There is a reciprocal relationship between both consequences of the symptom 
experience and the symptom experience itself and the influencing factors (Lenz et al., 
1997). 
The Theory of Unpleasant symptoms has been described as possessing antecedent factors 
or events that precipitate the symptom experience and its consequences or the results of the 
experience.  These antecedent factors include the physiologic, psychological and situational 
influencing factors (Brant, Beck, & Miaskowski, 2010; A. Gift, 2009).   Physiologic factors are 
antecedents that can affect the severity of the symptom (A. Gift, 2009).  Physiologic factors can 
include comorbidities, stages of disease, and other physical finding (A. Gift, 2009).   Psychologic 
factors such as mood, affective response and meaning ascribed to a symptom and situational 
factors related to the physical and social environment also act as antecedents influencing the  
symptom experience (A. Gift, 2009).  Demographic factors such as marital status, age, sex, race, 
and culture as well as social support, employment and access to healthcare have been described 
as additional situational factors (A. Gift, 2009).  When more than one symptom occurs at a time, 
they too may act as antecedents, influencing the symptom experience (A. Gift, 2009).  A critique 
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of models and theories of symptom management noted that  the antecedents and outcomes 
associated with the Theory of Unpleasant Symptoms need further refinement and, as such, may 
be open to interpretation (Brant et al., 2010). 
Concepts of the Theory 
 The Theory of Unpleasant Symptoms is composed of 3 primary concepts (Lenz & Pugh, 
2008; Lenz et al., 1997).  Figure 2 provides a visual overview of the theory.  These concepts 
include the symptom itself, with all of its dimensionality, influencing factors, or factors that can 
influence the symptom experience, and performance or the outcome of the symptom experience 
(Lenz et al., 1997).  Influencing factors include the 3 categories of physiologic, psychologic and 
situational factors (Lenz & Pugh, 2008; Lenz et al., 1997).  These 3 factors are described as 
influencing the predisposition to or manifestation of a symptom(s) and the symptom experience 
(Lenz & Pugh, 2008).   The symptom experience includes the multidimensional subjective 
experience of the symptom or symptoms as influenced by physiologic, psychologic, or 
situational factors (Lenz & Pugh, 2008).  The symptom experience affects the individual’s 
performance that can encompass cognitive, physical, and social functioning. (Lenz & Pugh, 
2008).  These performance outcomes can feedback as modifiers affecting the symptom 
experience or the influencing factors (Lenz & Pugh, 2008). 
Conceptual Definitions 
Symptom(s) are the central focus and concept in the Theory of Unpleasant Symptoms 
(Lenz & Pugh, 2008; Lenz et al., 1997).  Symptoms are defined as “the perceived indictors of 
change in normal functioning as experienced by patients” (Lenz & Pugh, 2008, p. 164).  This 
theory notes that often more than one symptom is experienced at a time with each symptom 
conceptualized as a multidimensional experience (Lenz et al., 1997).   Dimensions addressed by 
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this theory and common to many symptoms,  include intensity, timing, distress, and quality 
(Lenz et al., 1997).  The intensity dimension refers to the severity, amount, degree or strength of 
the symptom experienced (Lenz & Pugh, 2008; Lenz et al., 1997).  The timing dimension refers 
to variable frequency or duration of the symptom or a combination of both (Lenz et al., 1997).  
Timing can also refer to a relationship of a symptom to an event (A. Gift, 2009). The distress 
dimension refers to the how much the person is bothered by the symptom (Lenz et al., 1997) or 
their reaction to the sensation (A. Gift, 2009).  The quality dimension of a symptom refers to 
what it feels like to have the symptom or the unique way that the individual experiences the 
symptom and it includes descriptors used by the individual to describe the symptom (Lenz & 
Pugh, 2008; Lenz et al., 1997).  The quality dimension has also been described as including the 
location of the symptom or the reaction to an intervention (A. Gift, 2009). 
Influencing factors include three categories that can individually or collectively influence 
how the symptom(s) with all of its dimensions is experienced (Lenz & Pugh, 2008; Lenz et al., 
1997).  Influencing factors include physiologic, psychologic, and situational factors (Lenz et al., 
1997).  Physiologic factors that can influence symptoms are described by the Theory of 
Unpleasant Symptoms as including the interrelated components of normally functioning bodily 
systems, energy level, and the existence of pathology (Lenz et al., 1997).  These factors have 
been further described as also including genetic and treatment related variables (Lenz & Pugh, 
2008). Psychological factors are described as affective (mood) mental or cognitive states that 
may influence the meaning and or experience of a symptom (Lenz et al., 1997). Psychologic 
state prior to, during, or in response to the experience of the symptom has been noted to 
influence the symptom (Lenz & Pugh, 2008). Uncertainty regarding knowledge of the meaning 
of a symptom is a cognitive factor that can also influence the symptom experience (Lenz & 
Pugh, 2008).  Situational factors are described by the Theory of Unpleasant Symptoms as social 
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or physical environmental factors that may influence the meaning or experience of a symptom 
(Lenz et al., 1997).  Situational factors include the social and/or physical environment such as 
cultural, financial resources, lifestyle, healthcare access, employment, and/or social support 
(Lenz & Pugh, 2008; Lenz et al., 1997). 
Performance outcomes are described by this theory as the consequences or the effect of 
the symptom experience (Lenz et al., 1997).  This theory proposes  that effects of the symptom 
experience can affect functional performance (physical activity, social activities, and role 
performance) and/or cognitive (thinking, problem solving) outcomes (Lenz et al., 1997). It has 
been suggested by the developer of the theory that current evidence may warrant the addition of 
quality-of-life and or affective outcomes to the performance outcomes of this theory (Lenz & 
Pugh, 2008). 
Utility of the Theory of Unpleasant Symptoms in Research 
 The Theory of Unpleasant Symptoms is a useful middle range theory for guiding nursing 
research.  This middle range theory is useful because it highlights aspects of the phenomenon 
associated with the symptom experience thereby providing a structure for the study of the 
experience (Lenz et al., 1997).  Additionally, this theory allows for the prediction of patient 
responses that can be useful in the development of interventions (Lenz & Pugh, 2008; Lenz et 
al., 1997).  The concepts associated with this theory are measureable (A. Gift, 2009; Lenz et al., 
1997).  The dimensions and interactive nature of one or more symptoms can be assessed 
allowing for a greater explanation of the complexity of the experience so that interventions can 
be developed to minimize the negative aspects and maximize the positive aspects of the 
experience.  Physiologic, psychologic, and situational factors that influence the symptom 
experience can be assessed and this information can be used to guide the development of 
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interventions in an effort to enhance performance outcomes (Lenz et al., 1997).  The symptom 
experience directly influences performance outcomes that can be measured as functional or 
cognitive status. This theory has been described as needing refinement in multiple areas with one 
area being that of performance outcomes (Lenz & Pugh, 2008).  It has been suggested that 
quality-of-life with its affective aspects may be a more inclusive measure of performance than 
functioning alone and that this issue needs further exploration (Lenz & Pugh, 2008). 
Review of Research Using the Theory of Unpleasant Symptoms 
 Numerous studies have examined the utility of the Theory of Unpleasant Symptoms to 
understand the patient’s experience of unpleasant symptoms (Corwin, Brownstead, Barton, 
Heckard, & Morin, 2005; A. G. Gift & Shepard, 1999; Jurgens et al., 2009; Liu, 2006; McCann 
& Boore, 2000; Reishtein, 2005; Rychnovsky, 2007; Woods, Kozachik, & Hall, 2010).  It has 
been noted that multiple studies of symptoms across the literature support the premises of the 
Theory of Unpleasant Symptoms linking symptoms and performance even though the theory was 
not used to guide the study (Lenz et al., 1997).   
Fatigue in postpartum woman has been studied by several investigators using the Theory 
of Unpleasant Symptoms (Corwin et al., 2005; Rychnovsky, 2007).  Using a prospective 
longitudinal descriptive design, Rychnovsky evaluated 109 (N=155) military women who 
completed the surveys at three different postpartum time periods (Rychnovsky, 2007).  Some 
findings of this study included both significant positive and negative correlations with various 
physiologic, psychologic, and situational factors (Rychnovsky, 2007).   Depression was 
positively correlated with fatigue at all time periods (r =.516; r = .557; r =.477; p <.05) 
(Rychnovsky, 2007). Moderate to high levels of fatigue were reported at all data collection 
points with almost half of the women reporting moderate fatigue at the time of return to work;  
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maternal anxiety during hospitalization explained 6 percent of the variance and maternal anxiety 
at 2 weeks explained 20 percent of the variance in fatigue at 6 weeks (Rychnovsky, 2007).  
These findings demonstrate the complexity of the fatigue experienced by postpartum military 
women (Rychnovsky, 2007).   
Similarly, other investigators used a correlational longitudinal study design to assess the 
role of postpartum fatigue in the development of postpartum depression using hypotheses 
generated via the Theory of Unpleasant Symptoms (Corwin et al., 2005).  Forty-two women 
were enrolled before 36 weeks of pregnancy and followed at multiple time points (Corwin et al., 
2005). Fatigue and stress experienced over time accounted for a progressively increasing amount 
of the variance from 36 weeks gestation to 28 days postpartum in depressive symptoms (fatigue: 
day 7 = 29%; day 14 =49%; day 28 = 59% and stress day 7 = 45%; day 14 =57%; day 28 = 77%)  
(Corwin et al., 2005).  Those who reported higher levels of fatigue (M=11.93, SEM= 1.67) on 
day 14 also scored significantly higher for symptomatic depression on day 28 in contrast to those 
reporting below average fatigue (M=4.94, SEM= .92; t(29) = -3.84; p = .001) (Corwin et al., 
2005).  This finding lead the authors to conclude that fatigue significantly contributes to 
postpartum depression (Corwin et al., 2005).  This study was noted to support the premises of the 
Theory of Unpleasant Symptoms in that fatigue was identified as a significant contributor to 
postpartum depression (Corwin et al., 2005). 
The Theory of Unpleasant Symptoms has been helpful in the study of symptoms 
associated with chronic obstructive pulmonary disease.  Using a measure of three of the four 
dimensions described by the Theory of Unpleasant Symptoms for fatigue and for dyspnea, Gift 
evaluated predictors of fatigue in 48 female and 56 male outpatients with chronic obstructive 
pulmonary disease (A. G. Gift & Shepard, 1999).  Findings of the prospective cross sectional 
analyses included dyspnea and physical symptoms explaining 42% of the variance in predicting 
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fatigue in both sexes and 67% for women alone (A. G. Gift & Shepard, 1999).  Dyspnea and 
physical symptoms were found to have a greater impact than the objective physiologic severity 
measures (A. G. Gift & Shepard, 1999).  Additionally, these symptoms were found to have a 
greater impact for predicting fatigue than did symptoms that emulated psychologic status (A. G. 
Gift & Shepard, 1999).  These finding imply that dyspnea and physical symptoms are more 
useful predictors of fatigue than disease severity or psychologic symptoms (A. G. Gift & 
Shepard, 1999). Based on these findings, the authors suggest that in this population interventions 
directed at dyspnea and physical symptoms may more useful for reducing fatigue than those for 
altering psychologic symptoms or physical status (A. G. Gift & Shepard, 1999).   
Using the Theory of Unpleasant Symptoms, Reishtein prospectively evaluated 77 males 
and 23 females with chronic obstructive pulmonary disease (Reishtein, 2005) to determine the 
effect of dyspnea, fatigue and sleep difficulty on functional performance.  In this study, dyspnea 
correlated with fatigue (r = .43; p =<.001), sleep difficulty (r = .39; p =<.001), dyspnea (r = -.54; 
p =<.001), and fatigue  r = -.24; p=<.01).  Despite these finding, sleep difficulty was not 
correlated with functional performance (Reishtein, 2005).  Dyspnea alone was found to 
significantly explain the variance (adding 19% for a total of 44%; p<.001 to the 25% explained 
by age and oxygen use) in functional performance (Reishtein, 2005).  Findings guided by the 
Theory of Unpleasant Symptoms resulted in the suggestion that focusing on the symptom 
dyspnea might be the best way to improve both symptoms in general and functional outcomes 
(Reishtein, 2005). 
 The symptom of fatigue has also been studied in those who require hemodialysis using 
the Theory of Unpleasant Symptoms (Liu, 2006; McCann & Boore, 2000).  Several studies have 
specifically assessed fatigue and its relationships to physiologic, psychologic, and situational 
factors (Liu, 2006; McCann & Boore, 2000).  Prospective cross sectional analyses of 119 
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Taiwanese hemodialysis patients demonstrated multiple findings that included the psychologic 
variable of depression, and the situational variable of age were significant predictors of fatigue 
explaining 62% of the variance when using a fatigue assessment scale as the dependent variable 
(Liu, 2006).  When using a depression assessment scale as the outcome, depression and the 
physiologic variable of urea reduction ratio explained 48% of the total variance (Liu, 2006). In 
this study, unemployed subjects (situational factor) reported higher levels of the fatigue 
(differences in fatigue score by employment t =4.33; p<.01) than did employed subjects (Liu, 
2006).  It was noted that patients at risk for experiencing problematic fatigue can be identified 
and interventions could be employed to promote positive outcomes (Liu, 2006).  In a similar 
study, prospective cross sectional analysis of questionnaire data returned via the mail by 39 of 50 
hemodialysis patients (25 male; 14 female) surveyed was analyzed to examine fatigue and its 
relationship to physiologic, psychologic and situational variables (McCann & Boore, 2000).   
Some of the findings from this study included fatigue being associated with the physiologic 
factors of sleep problems (r = .476; p=<.01), poor physical health ( r = -.775; p =<.01) and the 
psychologic factors of depression (r = .647; p =<.01) but not with the physiologic factors of 
biochemical or situational factors (role function, employment status and others) (McCann & 
Boore, 2000).  The authors suggested that complex interactions occur at the level of physiologic 
and psychologic factors that may influence the fatigue experienced (McCann & Boore, 2000). 
Using hypotheses generated from an adapted version of the Theory of Unpleasant 
Symptoms, Woods and associates studied 157 abused women (N=162) analyzing the 
contributions of situational, psychological, and physiological factors on subjective sleep quality 
(Woods et al., 2010).   Findings suggested that the psychologic factor of posttraumatic stress 
disorder (ß=.33, p= <.01) and the physiologic factor of stress related physical health symptoms 
(ß=.22, p= <.01) mediated the effect of partner violence on sleep quality (Woods et al., 2010).  
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Variability in sleep quality was not significantly related to depression or the demographic 
variables in this study (Woods et al., 2010).  Physiologic, psychologic, and situational factors 
were found to be responsible for 32% of the variance in global sleep quality (Woods et al., 
2010).   This theory was also employed to develop hypotheses used to study the relationships of 
mood disturbances, symptom experience, and attentional function in female breast cancer 
patients (Lee, 2005).  This cross sectional correlational design study of 125 female Korean 
patients receiving chemotherapy for treatment of breast cancer found mood disturbance (r= -.46, 
p < .01) and symptom experience (r= -.20, p < .05) negatively correlated with attentional 
function as a measure of cognition (Lee, 2005).  Symptom experience was found to be a 
moderator, but not a mediator, between mood disturbance and attentional function 
(unstandardized regression coefficient b = -.081, t= -5.23 (SE=.015), p < .05), but only when 
symptoms were at a medium level rather than a low or high level (Lee, 2005).  The author 
suggests that interventions directed towards moderating the influence of mood disturbance on 
attention function may only be useful when symptoms are at a moderate level (Lee, 2005) 
The Theory of Unpleasant Symptoms has been used to study symptoms in those 
hospitalized with heart failure (Jurgens et al., 2009).  Findings from this secondary analysis of 
data from a heart failure registry (N=687) noted three symptom clusters that included acute 
volume overload, chronic volume overload, and emotional distress (Jurgens et al., 2009).  The 
acute volume overload symptom cluster that included shortness of breath, fatigue, and sleep 
problems explained the greatest variance (45.7%) on living as desired (Jurgens et al., 2009).   
Patients put different emphasis on different symptoms depending on whether the symptoms were 
acute or chronic demonstrating the utility of the Theory of Unpleasant Symptoms in 
understanding the multidimensional nature of symptoms as including more the physical 
sensation of the symptoms (Jurgens et al., 2009). 
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Conclusion 
The Theory of Unpleasant Symptoms provides a useful structure for this study as it 
highlights aspects of phenomena associated with the primary focus of the theory, that is the 
symptom(s), thereby allowing for examination of the experience of those with chronic cough 
(Lenz et al., 1997).   The dimensionality and interaction of one or more symptoms as described 
by this theory was useful in describing changes in the symptoms of depression, anxiety, and 
stress in adults with the symptom of chronic cough before and after management using the 
ACCP guidelines.   This theory provided a guide for the physiologic, psychologic, and 
situational factors that influence the experience of chronic cough.   
This study fit well with this theory that allowed for describing the relationship of factors 
that were  identified as physiologic factors (ability to speak without coughing, urge-to-cough, 
and number of diagnoses), situational factors (social support), and psychologic factors 
(symptoms of depression, anxiety, and stress) and the experience of chronic cough.  The theory 
provided a plan for the assessment of performance outcomes as a result of the experience of 
chronic cough.  This study advances the field by further exploring the role of the antecedent 
influencing factors for the symptom experience and the use of cough-specific quality-of-life as a 
performance outcome for the Theory of Unpleasant Symptoms.  Finally, this theory allowed for 
the prediction of patient responses to chronic cough that can be useful in the development of 
interventions (Lenz & Pugh, 2008; Lenz et al., 1997).  
Operational Definitions 
 In this study, concepts are operationalized in the following manner: 
1. Physiologic Factors are influencing factors that include number of cough-related diagnoses 
attributed to a patient by a cough clinic physician.  Physiologic factors will also include self 
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reported urge-to-cough and ability to speak being bothered by cough based upon intensity, 
timing, distress, and quality measured using Punum Ladder type of visual analogue scales. 
2. Psychologic factors are influencing factors that include symptoms of  depression, anxiety and 
stress  measured using the Depression, Anxiety, and Stress Scale 21 (P. F. Lovibond & S. H. 
Lovibond, 1995). 
3. Situational factors are influencing factors that include social support or the support of others 
or social relationships measured using the Duke-UNC Functional Social Support Scale 
(Broadhead et al., 1988) 
4. Symptom(s) are the self reported experience of chronic cough measured by a based upon 
intensity, timing, distress, and quality as measured using a Punum Ladder. 
5. Performance outcomes are cough-specific quality-of-life as measured by the Cough Quality 
of Life Questionnaire (C. T. French et al., 2002).  
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CHAPTER 3 
Methods 
Research Design 
This was a descriptive longitudinal observation study designed to examine changes over 
time in the psychologic symptoms of depression, anxiety, and stress in adults with chronic cough 
before and after management using the ACCP guidelines.  Factors examined for their potential 
influence on chronic cough were derived from the Theory of Unpleasant Symptoms. These 
factors included:  physiologic factors (ability to speak without being bothered by cough, urge- to-
cough and number of diagnoses), situational factors (social support), and psychologic factors 
(symptoms of depression, anxiety, and stress).  Findings revealed through quantitative analysis 
were used to provide further understanding of factors that may influence chronic cough.  Finally, 
intervention fidelity to the study components was monitored and a process for measuring 
intervention fidelity in the application of the ACCP guidelines for treating cough using the 
Technology Model has been described.  These findings were used to help understand the role of 
fidelity to the ACCP guidelines as can be applied to future studies of the management of chronic 
cough. 
Sample 
 The sample for this study was composed of a consecutive sample of patients recruited 
from a specialty cough clinic located at UMass Memorial Medical Center.  Patients were 
recruited from the spring of 2013, until a sample of 80 study participants were enrolled.  
 A power analysis was conducted for the analyses planned to address specific aims #1 
and #3.   Power analysis based on specific aim # 1 using a one-group paired t-test design and 
mean difference of .5, alpha = .05 and 80% power resulted in the recommendation for 56 
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subjects.  A linear regression analysis was conducted to address the power analysis for specific 
aim #3, using 7 predictors, an anticipated effect size (r2) of .3, alpha = .05, and 80% power, also 
resulting in the recommendation for 56 subjects.  To provide for a liberal 25 percent drop-out 
rate, 80 subjects were recruited.  This cough clinic draws patients from a wide geographic area 
and cares for approximately 2-4 new chronic cough patients each week.  Specific aim #4 was 
descriptive only and therefore did not require a power analysis.   
In an effort to improve subject interest and retention, subjects were informed that all 
names of those completing the study would be placed in hat for a drawing at the conclusion of all 
subjects three month data collection. One study participant received a Kindle Reader based upon 
the drawing. 
Inclusion and Exclusion Criteria 
Subjects were eligible for this study if they met the following inclusion criteria:  (1)  were 
age 18 years or older; (2) had a self reported cough of greater than eight weeks duration; (3) were 
able to read and speak English; and (4) had the ability to give written informed consent.  Subjects 
were excluded if they: (1) were pregnant; (2) had a cognitive disability that renders them unable 
to provide written informed consent; and/or (3) were prisoners.  The principal investigator 
documented the number of participants who declined to participate and the number excluded 
based on the exclusion criteria and the reason(s) for non-participation.   
Setting 
This study was conducted at UMass Memorial Medical Center (UMMMC), an academic 
medical center and clinical partner of the University of Massachusetts Medical School.  The 
specific site for the study was the internationally recognized cough specialty clinic located within 
the Lung and Allergy Center on the University Campus, in Worcester, Massachusetts.  The 
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cough clinic fully embraces the use of the American College of Chest Physicians’ Diagnosis and 
Management of Cough: American College of Chest Physicians (ACCP) Evidence Based Clinical 
Practice Guidelines (Irwin, Baumann, et al., 2006). This site and practice were chosen as it 
attracts a continuous population of new patients with a chief complaint of chronic cough.  The 
cough clinic attracts referrals from primary care physicians, pulmonologists, otolaryngologists, 
and gastroenterologists from Massachusetts and from across the US, Canada, and beyond.  The 
cough clinic is staffed by four board certified pulmonary and critical care physicians who are 
experts in the use of the ACCP guidelines.  The director of the cough clinic serves as the chair of 
the ACCP Cough Guideline Committee.  The principal investigator serves as a member of both 
the ACCP Cough Guideline Committee and its Executive Committee. 
Procedures  
The principal investigator (PI) works as a clinical care coordinator and nurse practitioner 
for the cough clinic, and as such, plays a role in the triage of patients into the cough clinic.  The 
patient scheduling coordinator, for the cough specialty clinic, provided the principal investigator 
with the names, medical record numbers, and phone numbers of  new patients who called to 
book a visit in the cough specialty clinic (a HIPAA waiver was obtained).  The principal 
investigator called all of these patients on the telephone prior to their appointment in the cough 
specialty clinic and offered them the opportunity to participate in this study.  The investigator 
asked patients who did not want to participate if they would be willing to share the reason why 
they chose not to participate.  A flow diagram was used to document the number and status of 
participants during each phase of data collection. 
For those patients who met study eligibility criteria and who were interested in 
participation, an appointment to obtain both written informed consent and initial data was 
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scheduled.  Patients were advised that the initial consent and data collection process would take 
approximately one to two hours.  This allowed plenty of time for questions during the consent 
process.  This appointment was conducted in a private setting and on a day deemed acceptable 
by the potential research participant.  The consent form was reviewed with potential participants. 
The consent form noted that the purpose of the study was to examine factors including symptoms 
of depression, anxiety, and stress, cough severity, their number of medical problems, their ability 
to speak being bothered by cough, urge-to-cough, and how the support provided by others may 
influence chronic cough and its effects on quality-of-life.  Participants were informed that we 
would also be measuring fidelity to the study and their receipt of the interventions.   It was noted 
that the results would be used to better understand chronic cough and to generate 
recommendations for future interventions. Potential participants were allowed time for questions.  
A copy of the signed consent form was provided to those willing to participate. Data collection 
was conducted in five phases. See Figure 3. 
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Recruit Eligible Chronic Cough Patients
No, Declines ParticipationYes, Interested in the Study
Verify Eligibility & Informed Consent Procedures Collect reasons for decline (deidentify)
Not Eligible or no longer interested
Yes: Eligible Informed Consent Obtained
Phase 1: Baseline Data Collection
Intervention
Phase 4: 3month follow-up: collect final data
Phase 2: Collect 
2nd Punum 
Ladders
Phase 5: Chart review to rate concordance
Phase 3: 
Observed visits
 
 
Figure 3. Flow diagram of the participants’ progress thorough the study 
 
Phase One Data Collection 
Initial data collection began after completion of the consent process.  Research 
participants were asked to complete a short sociodemographic questionnaire, the Cough Quality 
of Life Questionnaire (CQLQ), separate Punum Ladders for rating both urge-to-cough (whether 
or not cough was produced), ability to speak being bothered by cough, and cough severity based 
upon rating of timing, distress, intensity, and quality (Lenz et al., 1997), the Depression, Anxiety, 
Stress Scale (DASS-21), SF12v2, and the Duke Functional Social Support Scale using paper and 
pen self report questionnaires.   
Phase Two Data Collection  
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To examine test-re-test reliability for the Punum Ladder measure, research participants 
returning on separate days 24-48 hours apart prior to their initial visit with the physician were 
asked if they would be willing to complete the three Punum Ladders on two separate occasions.  
The second Punum Ladders were completed within 48 hours of the first and prior to physician 
appointment in the cough specialty clinic.   
Phase Three Data Collection 
 To establish intervention fidelity to the study components 12 patient physician cough 
clinic visits were scheduled to be observed by the principal investigator.  Fidelity in the 
application of the ACCP guidelines was measured by the principal investigator using an 
intervention fidelity checklist adapted specifically for this study. 
Phase Four Data Collection 
Follow-up data collection was completed 3 months after the initial physician visit and 
post initiation of the intervention.  Data collected included all prior questionnaires, minus the 
sociodemographic survey and included the addition of a subject intervention receipt 
questionnaire.   Subjects were contacted via phone and reminded that it is time for the three 
month data collection.  If research participants did not return to the clinic for in person data 
collection, they were mailed the questionnaires and a prestamped self-addressed envelope.  If 
questionnaires were not returned, the principal investigator contacted patients via telephone to 
see if they received the reminder.  Additional, reminders consisting of a postal letter, or a phone 
call, were conducted up to twice within 4 weeks and then the data were considered “missed” at 4 
months.   
Phase Five Data Collection 
The electronic medical record was reviewed after the 3 month data collection was 
completed to collect the following: medications that are known to cause cough, antihistamines, 
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bronchodilators, and decongestants, diagnoses, and diagnostic and therapeutic interventions 
prescribed. See Appendix H for data extraction sheet.  Additionally, during the 3 month post data 
collection review, the electronic medical record was reviewed to evaluate concordance between 
what was prescribed and participant receipt within the context of the individual situation.   The 
principal investigator determined and rated the degree of concordance between these two sources 
of information using a single variable. 
Measures 
Sociodemographic Questionnaire 
 Data collected using a sociodemographic questionnaire was used to characterize the 
population.   Demographic variables included age (in years), duration of cough, gender, marital 
status, educational level (in years), self-reported race and ethnicity, financial strain (Gold et al., 
2001) employment status, use of self prescribed medications, herbal or other home remedies and 
were collected using a self report survey administered at the initiation of the study. See Appendix 
A. Subjects were given the opportunity to respond to an open ended question at the end of the 
survey asking them to provide any additional information about their chronic cough. The 
investigator collected baseline medications and diagnoses from the electronic medical record at 
the 3 month post data collection period.  
Cough Quality of Life Questionnaire 
Consequences of chronic cough were measured using the Cough Quality of Life 
Questionnaire (CQLQ).  The CQLQ is a 28-item self report cough-specific quality-of-life 
questionnaire developed for use with patients complaining of acute or chronic cough.   This 
questionnaire does not include a referent time period, patients are asked to rate the impact of 
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cough on the items for their current state.  See Appendix B.  The CQLQ takes six to eight 
minutes to complete (C. T. French et al., 2002). Each item is scored on a four point Likert type 
scale (1-4): strongly disagree (1), disagree (2), agree (3), or strongly agree (4). Scores are 
determined by summing the individual item scores.  The lowest possible total overall score of 28 
indicates no adverse effects on quality-of-life because of cough. The highest possible total score 
of 112 is indicative of the most adverse effects of cough on quality-of-life. The CQLQ consists 
of six subscales that assess the following domains: physical complaints, psychosocial issues, 
functional abilities, emotional well-being, extreme physical complaints, and personal safety 
fears.  Internal consistency reliability has been demonstrated using data from both those with 
acute and chronic cough (N=184), with Cronbach alphas ranging from .62-.86 for the subscales 
and .92 for the total CQLQ score (C. T. French et al., 2002).   Test-retest reliability (chronic 
coughers n=154; 38 male and 116 female) demonstrated excellent reliability (total CQLQ r=.89; 
p <.001 and subscales ranged from r= .75-.92; p<.001) (C. T. French et al., 2002).  Construct 
validity was supported in a study with a sample of 24 chronic coughers who demonstrated 
significant improvement in post treatment CQLQ scores when cough was self reported as no 
longer being a problem (pretreatment scores for total CQLQ mean 63.33, SD = 13.69 versus 
30.50; SD = 5.80; paired t = - 10.73; p <.001) (C. T. French et al., 2002).  Using prospective 
measures, the minimal important difference has been reported as 21.89 for change CQLQ 
quality-of-life (Fletcher et al., 2010). 
Punum Ladders 
Separate Punum Ladders were used to rate the physiologic factors of ability to speak 
without coughing, and urge-to-cough.  Cough severity was also measured using a Punum ladder.  
All Punum Ladders asked that the dimensions of timing, intensity, distress and quality (Lenz et 
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al., 1997) of be taken into account when rating the issue and that the rating take the past 7 days 
into account (Fletcher et al., 2010).  The Punum Ladder is a self report scale that uses three 
anchoring cues: faces (0 smiling to 10 tearful), words (0 no problem to 10 worst possible 
problem; in the case of cough severity the word problem was replaced with cough), and 
numbered steps on a ladder (bottom rung no problem to top rung worst problem) and scores 
range from 0-10 with higher scores indicating more dysfunction (Fletcher et al., 2010).  See 
Appendix C.  Administration time is approximated at one minute per ladder.  
Depression Anxiety and Stress Scales 
Background: The clinical overlap of general affective distress and symptomatology 
associated with anxiety and depression has made quantitative measurement specific to the 
differentiation of these two disorders complex (Clark & Watson, 1991; Henry & Crawford, 
2005).  In an effort to resolve this problem, a tripartite model of anxiety and depression has been 
proposed (Clark & Watson, 1991).   The structure of this model includes a “general distress 
factor and specific factors for anxiety and depression” (Clark & Watson, 1991, p. 316).   The 
tripartite model also proposed that the anxiety component of the model is differentiated from the 
depression component in that anxiety  alone is marked by physiologic hyperarousal whereas 
depression alone is marked by the absence of positive affect or anhedonia (Clark & Watson, 
1991).   The model proposes that in addition to sharing common symptoms, those with both 
anxiety and depression share a general state of affective distress or highly negative affect 
supporting the presence of mixed anxiety and depression (Clark & Watson, 1991). 
Measure: Psychological influencing factors of symptoms of depression, anxiety, and 
stress were  measured using the Depression Anxiety Stress Scales (DASS-21), a 21 item self 
report questionnaire (Antony, Bieling, Cox, Enns, & Swinson, 1998).  
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  Subjects reply to each question by rating the degree to which the statement applies over 
the past week using a four point (0-3) Likert type scale with higher scores indicating a greater 
degree of severity of anxiety, depression, and stress.  Administration time for the DASS-21 is 
approximately five minutes.   
The DASS-21 (21 item) was derived from the DASS (42 item) (Antony et al., 1998). The 
DASS-21 was chosen for this study despite the fact that it has slightly lower reported reliability 
than the DASS (.94, .87, and .91. for the DASS-21 versus .97, .92, .95 for the DASS ) (Antony et 
al., 1998) because it has good psychometric properties, is shorter and will therefore  impose less 
burden on the participants (Antony et al., 1998).  The DASS-21 was also chosen for it 
similarities to the tripartite model proposed by Clark and Watson (Antony et al., 1998; P. F. 
Lovibond & S. H. Lovibond, 1995).  The DASS was designed to define separate core symptoms 
of depression, anxiety, and stress that would allow for differentiation between the conditions (S. 
H. Lovibond & P. F. Lovibond, 1995).  The DASS anxiety scale (7 items) is reflective of the 
symptoms associated with various Anxiety Disorder defined by DSM-IV (Brown, Chorpita, 
Korotitsch, & Barlow, 1997).  The developers of the DASS describe anxiety as involving long 
term anticipation of adverse events such as those that are of major significance to self esteem (S. 
H. Lovibond & P. F. Lovibond, 1995). Anxiety is more likely to occur in those with a low 
threshold for fear (S. H. Lovibond & P. F. Lovibond, 1995).  The DASS anxiety scale 
additionally addresses situational anxiety (S. H. Lovibond & P. F. Lovibond, 1995).  The DASS 
depression scale (N=7 items) is reflective of the DSM-IV criteria for Mood Disorders (S. H. 
Lovibond & P. F. Lovibond, 1995).  The developers of the DASS describe depression as more 
than a state characterized by sadness, in that it is a state of loss of self esteem or incentive 
associated with a low self perceived probability of achieving significant life goals (S. H. 
Lovibond & P. F. Lovibond, 1995).  The third component identified by the DASS is the stress 
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scale (7 item), which in contrast to the tripartite model, is not derived of commonalities of 
symptoms, but is correlated with common causes of anxiety and depression (S. H. Lovibond & 
P. F. Lovibond, 1995).  The stress scale reflects symptoms associated with over arousal or 
tension reflecting ongoing difficulty in meeting life demands (P. F. Lovibond & S. H. Lovibond, 
1995).  Despite being correlated with the other scales, the DASS stress scale is factorially 
distinct from the other scales (S. H. Lovibond & P. F. Lovibond, 1995).  The stress scale is 
proposed to potentially be helpful in exploring “links between environmental demands and 
emotional and physical disturbances” (P. F. Lovibond & S. H. Lovibond, 1995, p. 343) .   
The DASS was not designed as a tool to be used in categorizing a diagnosis (S. H. 
Lovibond & P. F. Lovibond, 1995).  The focus of the DASS-21 is the dimension of severity of 
the symptom and the risk of more extreme symptoms rather than categorizing symptoms using a 
single cut off score (S. H. Lovibond & P. F. Lovibond, 1995).  Lovibond noted that stress can 
precipitate symptoms of anxiety and depression and that it has a clear connection with anxiety 
(P. F. Lovibond & S. H. Lovibond, 1995). Cut off scores are available to augment an 
understanding of the degree of severity to symptoms in relation to populations.  It is 
recommended that during statistical analyses, the scores of the DASS-21 be doubled for 
interpretation as this most closely represents the original DASS (S. H. Lovibond & P. F. 
Lovibond, 1995).   The 7 subscales are rated 0 -3 did not apply to me at all to applied to me very 
much, or most of the time.  Subjects are asked to respond based upon the past week.  Scores are 
determined by summing the individual item scores for each scale and multiplying them by 2, 
with subscale scores ranging from 0-42.  The total scale score ranges from 0-126. 
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SF-12v2 
The Quality Metric’s SF-12v2® Health Survey was used in this study as a measure of 
concurrent validity for the CQLQ.  The SF-12v2 is a commonly used self-report measure of 
functional health and well being developed as a shorter alternative to the SF-36v2® 
(QualityMetric, 2012).  This questionnaire uses 3 and 5 point response options and it takes 2-3 
minutes to be completed.  This version of the questionnaire is composed of 12 items that address 
eight domains with one to two questions per domain and two overall summary outcomes that 
address a physical and mental health component summary score as well as eight domain scores 
(J. E. Ware, Kosinski, Turner-Bowker, & Gandek, 2002).  Domains include physical functioning, 
role-physical, bodily pain, general health, vitality, social functioning, role-emotional, and mental 
health (J. E. Ware et al., 2002).  The acute recall version of the questionnaire used in this study 
was based on a one week recall period.  Test-retest reliability for the physical component 
summary was 0.89  and 0.76 for the mental component summary for a US population (J. Ware, 
Kosinski, & Keller, 1996).  The lowest possible scores reflect poor quality-of-life and highest 
reflect excellent quality-of-life.  Scoring was completed using the program provided by Quality 
Metrics.   
During its early development, results obtained with this questionnaire were shown to 
closely mirror the statistical outcomes of the 36 item version from which it was derived (J. Ware 
et al., 1996).  Earlier work demonstrated correlations between the SF12 and the SF36 ranging 
from 0.94 to 0.96 for the physical component summary and 0.94 to 0.97 for the mental health 
component summary (Gandek et al., 1998).  Reliability coefficients for the physical component 
summary score were 0.89 and 0.86 for the mental component summary score and the eight 
domains ranged from 0.73 to 0.87 (J. E. Ware et al., 2002). Only one study was found comparing 
any version of the SF with a cough questionnaire.  In a study of those with COPD (N=54) weak 
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to moderate correlations (r=0.04 to 0.41) were found  between similar components of the SF-36 
and the Leicester Cough Questionnaire (Berkhof et al., 2012).  
Duke-UNC Functional Social Support Questionnaire 
 The situational factor of social support was measured using the Duke-UNC Functional 
Social Support Questionnaire (FSSQ).  The 8 item FSSQ was derived by factor and item 
remainder analysis derived from a 14 item social support questionnaire (Broadhead et al., 1988).  
Psychometric testing of the 8 item FSSQ was performed with 401 subjects from a family 
medicine clinic; it demonstrated good reliability (test-retest r=.50-.77; p = .05) (Broadhead et al., 
1988).  The 8 item FSSQ is a self report questionnaire that uses a 5 category Likert type response 
format (ranging from 1 =as much as 5= I would like to much less than I would like) (Broadhead 
et al., 1989; Broadhead et al., 1988).  This questionnaire does not offer a referent time period.   
The total score is the sum of the individual scores.  Higher scores are indicative of greater social 
support.  Five minutes or less should be all that is required for completion of this questionnaire.   
The FSSQ measures two dimensions of social support that include confidant and 
affective support (Broadhead et al., 1989; Broadhead et al., 1988).  The confidant support scale 
includes five items and the affective support scale includes three items (Broadhead et al., 1989; 
Broadhead et al., 1988).  Confidant support relates to chances to talk about important issues, 
useful advice, and invitations to participate in activities (Broadhead et al., 1989).  The affective 
support scale relates to others who provide caring and affection as well as help when bed ridden 
(Broadhead et al., 1989).  Cronbach’s alpha of .88 for the total 8 item scale using the 5 response 
options has been reported in a study of HIV infected woman (N=101) and their adjustment to 
chronic illness (Bova, 2001) and .87 in a study of quality-of-life in ovarian cancer survivors 
(N=132) (Champion et al., 2007). 
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Intervention Fidelity 
A process for measuring intervention fidelity to the study components was developed 
using the ACCP guidelines (Irwin, Baumann, et al., 2006).  Intervention fidelity was  evaluated 
based upon the Technology Model (Santacroce et al., 2004). We developed a detailed 
intervention manual to help guide the interventionist in the application of the ACCP guidelines. 
The intervention that was the focus of this study was the application of the 2006 American 
College of Chest Physicians’ Diagnosis and Management of Cough: American College of Chest 
Physicians (ACCP) Evidence Based Clinical Practice Guidelines (Irwin, Baumann, et al., 2006).    
Development of an Intervention Manual 
An intervention manual was developed to serve as the baseline for the delivery of care for 
the diagnosis and management of chronic cough.  The purpose of the manual was to provide a 
basis for review to help ensure fidelity to the study components has been maintained as outlined 
in the manual.   The manual contents were derived from the 2006 American College of Chest 
Physician Guidelines for the Diagnosis and Management of Cough.  The algorithm for the 
management of chronic cough, a component of the 2006 guidelines, was used as the focus for the 
development of the clinical components of the manual.  The care outlined in the manual is the 
accepted standard of practice in the Cough Clinic at the UMass Memorial Medical Center. 
Clinical components of the manual included core diagnostic and management elements 
associated with the 4 most common causes of chronic cough and beyond and process elements 
that address issues relative to baseline cough evaluation and follow-up.  The intervention manual 
is included in this paper as Appendix D.   
The PI reviewed the manual with the 4 physicians providing care in the cough clinic prior 
to the onset of the study.  This review was conducted to establish agreement that the manual 
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outlined the care that the Cough Clinic physicians deliver, to those with cough of greater than 8 
weeks duration on a routine basis.  This care was in accordance with the 2006 ACCP Guidelines 
for the Diagnosis and Management of Cough.  The care outlined in the manual included baseline 
measurement of cough severity and follow-up visits scheduled at 4-6 weeks.  All 4 physicians 
agreed that the manual accurately outlined the care they deliver and they agreed to randomly 
undergo assigned observations of their patient care evaluation and management visits by the 
primary nurse investigator. 
The PI monitored the intervention delivery by direct observation of 15% of the visits 
(approximately 12 visits over the course of the study).  All research participants attended a face 
to face cough specialty clinic new patient visit.  Follow-up medical care was delivered in person 
or via phone call (when travel was not feasible) as is also the standard in the cough specialty 
clinic. It was expected that follow-up will occur in 4-6 weeks so at least one follow-up contact 
should occur during the three month follow-up period. Research participant care was managed 
by a physician and augmented by nurses, nurse practitioners, and nutritionists as is standard in 
this clinic.  
The intervention fidelity process focuses on monitoring for the prescribed behaviors by 
the physician that demonstrate adherence and competence in the delivery of treatment of 
identified causes of cough (Irwin, Baumann, et al., 2006).  The process also seeks to measure 
participant receipt of the interventions prescribed and concordance between what is prescribed 
and what is received.  Specifically, the intervention fidelity process assessed for evidence of 
prescribed focused and/or empiric treatment of:  
1) upper airway cough syndrome with first generation antihistamine/decongestants;  
2) asthma with inhaled corticosteroids and bronchodilators, and/or leukotriene receptor  
    antagonists; 
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3) non-asthmatic eosinophilic bronchitis with inhaled corticosteroids; and 
4)  gastroesophageal reflux with diet, lifestyle recommendations, acid suppression   
     medications, and prokinetic therapy if needed at each visit (Irwin, Baumann, et al., 
2006).   
Intervention adherence was defined as prescribing identified diagnostic interventions and 
focused and/or empiric therapy for identified causes of cough and avoiding proscribed 
recommendations (Santacroce et al., 2004).   Competence in intervention delivery was defined as 
probing for patient understanding of and adherence with prescribed therapy, maintaining 
partially effective therapy, stepping up ineffective therapy, and ordering further evaluation when 
therapy has been maximized and cough has not resolved. This study included three different 
measures of intervention fidelity.   
Measures of Intervention Fidelity 
Intervention fidelity was measured in three ways: 
1. Direct observation of interventionist and research participant cough clinic visits was 
conducted by the PI for a planned total of 12 random observations over the course of data 
collection.  Random numbers were generated using SPSS to generate a list of 56 numbers. 
The first 12 random numbers taken from this list were to be used to identify the research 
subjects whose visits will be observed.  The list was maintained for use in the event of 
research subject drop out.   
The PI unobtrusively sat in on patient visits with interventionists who volunteered to have 
their visits monitored to assess intervention delivery.  The observation goals were the 
measurement of the application of the ACCP cough management guidelines within the 
context of the patient visit.  Adherence to and dose of intervention delivery and competence 
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were measured using an Intervention Fidelity Monitoring Checklist.  This form was adapted 
from a form previously developed for use in a pediatric intervention study (Bova & Sullivan-
Bolyai).  This form also listed the most common diagnoses and treatments for chronic cough 
and provided space to write in others. The rater was asked to check diagnoses and treatments 
for chronic cough that were addressed during the visit   This 7 item  rating form  addresses 7 
processes of care delivery associated with the use of the cough guidelines.   The form uses a 
4 point scale (0-3) point scale. The scale includes 0- none; 1= low level of intervention 
fidelity (2 or less of the 4 most common causes addressed); 2 moderate level of intervention 
fidelity (3 or more of the 4 most common causes addressed); 3=high level of intervention 
fidelity (all 4 of the most common causes addressed).  Scores may range from 0 (lowest 
fidelity) to 21 (highest fidelity).  See Appendix E.   
2. Patient self report of receipt of the information related to the guideline interventions 
prescribed was measured using an Intervention Fidelity Questionnaire for Monitoring Patient 
Receipt Evaluation.  This form was adapted from a form previously developed for use in a 
pediatric intervention study (Bova & Sullivan-Bolyai).  This form also lists the most common 
diagnoses and treatments for chronic cough and leaves space to write in others. Subjects are 
asked to check off their conditions that the physician advised them were causing cough and 
the treatments advised to control the cough.  This evaluation uses a 3 point scale (0=not 
covered, not given any information; 1= covered somewhat, would have liked more 
information; and 2=covered completely, given all the information I needed) for subjects to 
rate 7 processes of care delivery associated with the use of the cough guidelines. Scores may 
range from 0 to 14 (highest fidelity). An additional 8th question (not part of the scale), asks 
the subject how closely they have followed the cough specialists’ recommendations and is 
rated on a 0-3 scale (0=none of the time, 1 = some of the time, 2= most of the time, 3= all of 
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the time).  The rating scales are followed by 3 open ended questions asking for comments on 
why they did not follow recommendations, other treatments prescribed, and anything else 
that may have changed since they began treatment.  These data were collected for all patients 
at the three month post initiation of intervention time point.  See Appendix F. 
3. Concordance with patient self report of receipt and interventionist prescribed care was   
established by electronic medical record (EMR) review (Allscripts EMR).  The PI rated the 
degree to which the research subjects’ self reported receipt corresponded with documented 
causes of chronic cough and prescribed interventions.  Concordance was rated and reported 
as a single and separate variable. A data concordance rating scale (see Appendix G) was used 
to rate the degree to which concordance found using a 0-3 point scale (0- not at all congruent; 
1= somewhat congruent (2 or less of the 4 most common causes congruent); 2 Almost all (3 
or more of the 4 most common causes congruent); 3=complete congruence (all 4 of the most 
common causes congruent).  Scores range from 0 (lowest concordance) to 3 (highest 
concordance).  The rating scale was adapted to the number of established diagnoses for each 
subject.  This form was adapted from a form previously developed for use in a pediatric 
intervention study (Bova & Sullivan-Bolyai).  
Data Collection 
 
The PI collected all self-report data via questionnaires.  Subjects were asked to complete 
all questionnaires by themselves in a private setting at baseline and at three months post 
initiation of the ACCP guidelines. Questionnaires were mailed to any subjects not returning in 
person for follow-up visits. Upon receipt of questionnaires, the investigator reviewed them for 
completeness. Attempts were made to reduce missing data by advising subjects who failed to 
complete an item that it was noticed that they had not completed an item and asking if they 
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would like the opportunity to do so or by calling the patient on the phone immediately upon 
receiving the questionnaire and doing the same.  
Data collection specific to observation of intervention fidelity was randomly assigned and 
collected as outlined under the section titled Measures of Intervention Fidelity.   
Data Management 
Data were stored on a University of Massachusetts secure research drive.  Each 
participant was assigned a unique research identification number.  A log identifying patients by 
name and unique identification number as well as any paper and pencil questionnaires was kept 
in a separate locked cabinet in the investigator’s office.  Only the principal investigator had have 
access to the locked cabinet.  Deidentified data were kept on a password protected drive at the 
University of Massachusetts Medical School that was backed up nightly.  Data collected during 
observation of visits and that generated by medical record review were deidentified and stored 
under the research participants deidentified study code. Data were uploaded to IBM® SPSS® 
Statistics 21 for analysis.  
Data Analyses 
Data were evaluated for missing values.  As the questionnaires were checked for missing 
data immediately upon completion and the investigator queried the subject as to whether they 
would like to complete the item. Descriptive statistics (frequencies, means, standard deviations, 
and percentages) were calculated for all study variables as appropriate to the level of data.  For 
continuous variables, mean, median, skewness, standard error of the mean, standard deviation, 
and histograms were calculated.  Frequencies were run on all categorical variables. All 
continuous variables were checked for normal distribution.  Internal consistency reliability was 
evaluated using Cronbach’alpha for all multi-item scales.    
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Data collected using the sociodemographic survey was described using descriptive 
statistics and measures of central tendency to characterize the population.  Physiologic factors 
were characterized by number of diagnoses, focusing on those related to cough, ability to speak 
being bothered by cough, and urge-to-cough.  The situational factor of social support was 
described using results obtained from the FSSQ and the psychologic factors were described 
using data from the DASS-21.   To further support validity for the CQLQ, Pearson Correlations 
were conducted to establish concurrent validity for the CQLQ and the SF12v2 using total scores 
of the CQLQ and the two primary SF12v2 scores.  Test-retest reliability for the cough severity, 
ability to speak being bothered by cough, and urge to cough Punum Ladders was conducted 
using Pearson Correlations for 2 administrations of each of the Punum Ladders collected 24-48 
hours apart.  Data were coded for method of collection, in person or via postal mail.  A flow 
chart was developed to track number of participants and their status.   
For specific aim #1: describe the change in psychologic factors, symptoms of 
depression, anxiety, and stress from baseline to 3 months post standardized treatment for chronic 
cough the DASS-21  were collected at both time points.   Descriptive statistics were used to 
compute the DASS total score and the DASS depression, anxiety, and stress subscale scores.  
Using Fisher’s measure of skewness these scores were found to be significantly skewed at 
baseline (range 3.06 to 6.36).   The non parametric statistical test, Related Samples Wilcoxon 
Signed Rank Test was computed to evaluate change between baseline and the 3 month post 
treatment for chronic cough data.   To determine change in the situational factor of social support 
similar analyses were conducted for the FSSQ total score (skew range -2.21 to -2.56).  To 
determine whether or not there were differences in psychologic factors related to medications 
used the non parametric Mann Whitney U was employed. 
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For the specific aim #2: determine the relationship between baseline cough severity and 
cough-specific quality-of-life with baseline urinary incontinence, financial strain, employment; 
self prescribed remedy use, gender, marital status and education various statistical tests were 
conducted.  Due to skewed data, Spearman’s Rho Correlations were conducted for the 
continuous variables of cough severity and cough-specific quality-of-life and urinary 
incontinence, cough duration, and age.  Independent t-tests were used to determine the 
differences in the continuous variables cough severity and cough-specific quality-of-life and the 
categorical sociodemographic variables of financial strain (no financial strain or at least some 
financial strain), employment (employed or not employed), self prescribed remedy use (yes used 
or no not used), gender (male or female), marital status (married or not), and education (less than 
college or college or more).   
For specific aim #3: describe the influence of physiologic factors (urge-to-cough, 
number of diagnoses, ability to speak without coughing), situational factors (social support) and 
psychologic factors (symptoms of depression, anxiety, and stress) on cough-specific quality-of-
life and cough severity (global symptom measure of timing, intensity, distress, and quality) at 
baseline and at 3 months post standardized treatment various statistical tests were conducted.   
Due to skewed data unadjusted associations were assessed for using Spearman’s Rho correlation 
for all variables first at baseline. Subsequently, Spearman’s Rho correlations were conducted 
seeking relationships between baseline cough severity and cough-specific quality-of-life and 3 
month post treatment scores for physiologic, situational and psychologic variables. Analysis of 
Variance (ANOVA) was then used to assess for unadjusted association for the categorical 
variables of self prescribed remedies, gender, employment, marital status, education, and 
financial strain and baseline cough severity and cough-specific quality-of-life.  The assumptions 
of one-way ANOVA were met in that: the continuous dependent variables were normally 
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distributed; the groups were independent of each other.  and homogeneity of variance was 
present (Munro, 2005). 
Hypothesis #1.  To evaluate the associated hypothesis, that treatment of chronic cough 
using the ACCP guidelines will result in improvement in cough severity with subsequently 
improvements in cough-specific quality-of-life various statistical tests were conducted. 
Sequential paired t-tests were used for normally distributed data and the non-parametric Related 
Wilcoxon Signed Rank test for skewed data.   
Hypothesis #2.   To evaluate whether physiologic factors (ability to speak without coughing, 
urge- to-cough and number of diagnoses), situational factors (social support), and psychologic 
factors (symptoms of depression, anxiety, and stress) predict cough severity (timing, intensity, 
distress, and quality) Spearman’s Rho correlations were conducted,  
Hypothesis #3. Cough severity (timing, intensity, distress and quality) predicts cough-
specific quality-of-life, that collectively if improvements are found in cough severity and quality-
of-life they will result in improvements in psychological factors, physical factors, and situational 
factors Spearman’s Rho correlations were conducted. 
For specific aim #4: describe a process of measuring intervention fidelity in the 
application of the ACCP guidelines using the Technology Model; a manual was developed to 
guide the interventionist and the monitoring process related to the intervention delivery.  Existing 
scales were described earlier in this chapter and used in monitoring intervention delivery, receipt, 
and concordance of understanding by the clinician and participant receipt of the intervention.  
Descriptive statistics were used to describe the dose, adherence and competence of intervention 
delivery, participant receipt, and concordance of documented intervention delivery and 
participant receipt to the ACCP guideline-based intervention.   
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Human Subject Considerations 
Approval was received from the Human Subjects Committee of the Institutional Review 
Board (IRB) at the University of Massachusetts Medical School prior to conducting this study 
(Docket # H: 00000732).  Participants were identified for recruitment based upon obtaining a 
HIPAA IRB Waiver of Authorization.  Research participants were told the purpose of the study 
and were advised that participation is voluntary and that responses will be kept confidential.  
Coercion was avoided by sending participants the consent in advance or explaining the study to 
them over the phone in advance, so that they had the chance to contemplate the study and to 
develop their response to the invitation to participate.  Participants were also advised of their 
rights regarding withdrawal from the study at any time and that refusal to participate will not 
affect their care in any way.  Each participant was asked to sign an IRB approved informed 
consent that fully explains study procedures as well as an “Authorization to Disclose Protected 
Health Information for Research Purposes” consent form (to allow for review of their medical 
record).  A copy of the consent form complete with contact information for the PI was given to 
participants who were verbally advised to contact the investigator if problems related to the study 
arose.  
No physical risks were expected.  Some participants may have experienced some 
emotional distress at being asked to complete questionnaires describing their experiences. We 
anticipated that this risk would be minimal. Participants were advised that the questionnaire 
results will not be available real time and that after completion of the questionnaires the PI would 
ask if they have any serious concerns related to what they shared in the questionnaires, noting 
that the investigator was willing to help them decide if they or the investigator should contact 
their primary care physician.   
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There were no direct benefits for participants of this study.  This study may help others in 
the future by helping to expand knowledge in the area of chronic cough in an effort to further 
research to help others. 
Potential Difficulties 
Potential difficulties were related to enrollment. Difficulties could have occurred if an 
inadequate number of participants were available.  If enrollment was inadequate, the addition of 
another site could have been considered.   While there were no problems with enrollment, it was 
quickly realized that there would be a problem with drop-outs, and an extra 10 subjects were 
added with IRB approval.    
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CHAPTER 4 
Results 
This chapter describes the results of this study that used the Theory of Unpleasant 
Symptoms (Lenz et al, 1997) to examine changes in psychologic factors, physiologic factors, and 
situational factors in adults after management of chronic cough using the standard treatments 
outlined in the 2006 ACCP Guidelines.  This chapter also presents an analysis of intervention 
fidelity related to the application of the 2006 ACCP Cough Guidelines in this study population. 
The sociodemographic variables associated with this study are described for the baseline 
period and 3 months post treatment.  These data are followed by study results that are presented 
and categorized according to the study’s 4 specific aims and the 3 associated hypotheses. 
Sociodemographic Variables 
 During the recruitment period, February 7th 20013 through June 27th 2013, 111 
consecutive patients seeking care for cough of greater than 8 weeks duration were offered the 
opportunity to participate in this study.   Fifteen patients refused participation and therefore were 
not screened for study participation.  Ninety-six subjects were screened with 16 not meeting 
inclusion criteria. Reasons for not meeting inclusion criteria included, medical conditions 
resulting in impaired cognition due to developmental disorders (n = 3); cough resolved prior to 
the scheduled Cough Clinic appointment (n = 2); pregnancy (n = 3);  and non English speaking 
(n = 8).  Of the initial 111 patients seeking care for chronic cough, 80 were enrolled as study 
subjects (see Figure 4).  Seventy-eight (97.5%) of the 80 baseline questionnaires were collected 
in person with the other 2 being completed and returned via mail prior to the initial visit.  At 3 
months, 65 questionnaires were collected, 9 in person and 56 by mail.  
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CONSORT Flow Diagram 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4. Consort diagram summarizing the flow of study subjects from screening for 
eligibility through 3 months post initial treatment. 
Table 1 and Table 2 summarize the categorical and continuous sociodemographic data 
respectively for study subjects.  Initially enrolled subjects (N=80) were predominately middle 
aged, mean age was 58.54 (SD=11.10) years; the majority were female (68.7%) and white 
(98.7%).  Those enrolled were predominately non-smokers (97.5%) and most (75%) used self 
prescribed remedies for cough.  More than half were married (66.2%), employed (63.7%) and 
had at least a college education (68.7%).  The majority of subjects (73.7%) were financially 
stable reporting little to no financial strain.   
Assessed for eligibility (N=111) Excluded (n=31) 
   Not meeting 
inclusion criteria 
(n=16)  
   Declined to 
participate (n=15) 
Study Subjects Completing 3-Month Follow-Up (n=65) 
Analysed (n=65); Lost to follow-up (n=15) 
 Completed only baseline questionnaire and did not 
attend any MD appointments (n=1) 
 Withdrew (n=4)  
 Subjects no longer interested (n=10) 
Enrolled Study Subjects (N=80) Baseline 
Three Months 
Enrollment 
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Most subjects had a chronic cough for years with the mean cough duration being 85.99 
(SD=123.67) months.  Mean cough severity rated on a scale of 0-10 (zero no cough and 10 worst 
possible cough) was 6.11 (SD=2.22).   
Table 1 
Baseline Demographic Data for Categorical Variables for Those Initially Enrolled (N=80)  
Variable      n   (%) 
Female Gender   55 (68.7)   
Male Gender    25 (31.3) 
Smokers*       2    (2.5) 
Marital status    
Single      8 (10.0)  
Married    53  (66.2) 
Widowed      6    (7.5) 
Divorced    12 (15.0) 
Significant other    1    (1.3) 
Employed     51 (63.7) 
Highest Level of Education  
Less than high school   1    (1.3)  
High school   24  (30.0) 
College    35 (43.7) 
Graduate school  20  (25.0) 
How Hard is it to Pay for Basics 
Don’t know       1    (1.3) 
Refused      3    (3.8) 
Very hard      2   (2.5) 
Somewhat hard   15 (18.7) 
Not very hard at all  59  (73.7) 
Race 
 White    79 (98.7) 
 American Indian    1   (1.3) 
Ethnicity 
 Hispanic or Latino    4   (5.0) 
 Not Hispanic or Latino 76 (95.0) 
Self Prescribed Remedy  60    (75) 
Note.  n=77 for smokers due to missing data for 3 subjects  
 
 
 
 
 70 
Table 2 
Baseline Demographic Data for Continuous Variables for Those Initially Enrolled (N=80) 
Variable      M    Mdn        (SD)             Range 
Age in years    58.54    61.0    (11.10) 24-79 
Cough duration in months  85.99    24.0  (123.67)  2.5-600 
Cough severity (0-10)       6.11      6.0      (2.22)  1-10* 
Note.  *Range possible of scores is 0-10 with no cough =0 and worst possible cough = 10.  M= 
mean; Mdn= median; SD=standard deviation. 
 
 The baseline influencing factor clinical characteristics of the study subjects initially 
enrolled (N=80) are shown in Table 3.  These data are categorized using the physiologic, 
psychologic, and situational influencing factors, as described by the Theory of Unpleasant 
Symptoms.   
Table 3 
Baseline Influencing Factor Clinical Characteristics (N=80) 
Clinical Characteristic   M    Mdn  (SD)         Range 
Physiologic Factors 
Urge-to-cough   5.91   6.00   2.40          1-10* 
Ability to speak bothered  5.21   5.00   2.97          0-10* 
 Number of diagnoses    
      (Presumptive)  2.28   2.00   0.81          1-5 
Psychologic Factors 
 DASS total score            26.65                22.00             21.33          0-106 
 DASS anxiety    8.60    6.00    8.13          0-40    
 DASS stress             11.45  10.00    9.01          0-38 
 DASS depression   6.60    4.00    7.06          0-28 
Situational Factors  
 FSSQ social support            33.42   34.00    6.00         16-40 
Note.  *Urge-to-cough and ability to speak (possible range 0-10; higher scores = worse 
symptoms); DASS = Depression, Anxiety, and Stress Scale 21 (subscale possible range 0-42; 
higher scores = worse symptoms);  Duke-UNC Functional Social Support Questionnaire = FSSQ 
(possible range 8-40; lower scores = less support than they would like).  M= mean; Mdn= 
median; SD=standard deviation. 
 
Sixty five subjects completed the 3 month data collection.  These 65 were similar in 
clinical and sociodemograpahic characteristics when compared to those initially enrolled (N= 
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80).  Independent t-tests revealed that these 65 subjects did not significantly differ from the 15 
who did not complete the 3 months data collection by baseline cough severity, urge-to-cough, or 
ability to speak being bothered by cough.  Chi Square analyses demonstrated that these 2 groups 
did not significantly differ by use of self-prescribed remedies, gender, marital status, financial 
strain (how hard is it to pay for basics like food, housing, medical care, and heating), 
employment or education.  Differences by race and ethnicity could not be evaluated due to the 
small number of racial and ethnic minorities in this sample.  
Causes of Chronic Cough 
Table 4 summarizes the frequency of number of cough-related diagnoses at the 3 month 
time period.  Table 5 describes the frequency of the type of diagnoses present in this sample.  
Diagnoses were collected via electronic medical record review for 75 of 80 subjects (5 subjects 
withdrew prior to record review).  The majority of subjects (75%) had 2 or 3 simultaneous 
diagnoses and the most frequent diagnoses were GERD, UACS, and asthma.  
Table 4 
Multiplicity of Cough-Related Diagnoses (N=80) 
 
Number of Diagnoses          Number               (%) 
One     12   (15.0) 
Two     34   (42.5) 
Three     26  (32.5) 
Four       2    (2.5) 
Five       1    (1.3) 
Missing      5    (6.2)* 
Note. *5 subjects of those initially enrolled (N=80) withdrew before the electronic medical 
record was reviewed. 
 
 Lung Nodules were not considered cough-related diagnoses but were revealed as part of 
the cough evaluation in 10 subjects (12.5%). 
 
 72 
Table 5 
Frequency of Presumptive Cough-Related Diagnoses Baseline (N=80) 
Individual Presumptive Diagnosis  n    (%)  
GERD     69  (86.3) 
UACS     58   (72.5)    
Asthma    22  (27.5) 
Drug Induced      4    (5.0) 
Bronchiectasis      3    (3.8) 
Post Infectious     3    (3.8) 
NAEB       2    (2.5) 
COPD       2    (2.5) 
Laryngeal Sensory Neuropathy   2    (2.5) 
CHF       1    (1.3) 
Bronchiolitis      1    (1.3) 
Infiltrate      1    (1.3) 
Supprative Airway Infection    1    (1.3) 
Vocal Cord Dysfunction    1    (1.3) 
Interstitial Lung Disease    1    (1.3) 
Note.  Note. UACS= upper airway cough syndrome; GERD = gastroesophageal reflux disease; 
NAEB= non-asthmatic esosinophilic bronchitis, COPD= chronic obstructive pulmonary disease; 
CHF= congestive heart failure.  
Reliability and Validity of Measures 
Seventeen subjects agreed to complete the test-retest component of the study.  The 3 
Punum Ladders were completed on 2 separate occasions within 48 hours.  Test-retest reliability 
for the 3 Punum Ladders demonstrated significant correlations of .8 or more as shown in Table 6. 
Table 6 
24-48 Hour Test-Retest Reliability using Pearson Correlations for Punum Ladders (n=17) 
    Cough Severity Urge-to-Cough Ability to Speak 
Cough Severity           .801**      
Urge-to-Cough            .902**     
Ability to Speak                  .892**   
Note.  **Significant at the 0.01 level (2 tailed).   
Internal consistency reliability of all multi-item scales used in the study was assessed at 
both baseline and at 3 months post treatment for chronic cough (see Table 7).  Data are reported 
 73 
for total scale scores for the CQLQ, DASS, and FSSQ.  Subscale scores are reported for the 
DASS Anxiety, Stress and Depression subscales and the SF12v2 Physical and Mental 
Component subscales for both time periods in Table 7.  All scales were found to have good to 
excellent reliability (range = .77-.94) at both baseline and 3 months post treatment. 
Table 7 
Scale Reliability Analyses Baseline and 3 Months 
Number of items /Scale       Cronbach’s Alpha    Cronbach’s Alpha 
         Baseline (N=80)      3 Months (n=65) 
28 Item CQLQ     0.92     0.94   
21 Item DASS     0.92     0.92 
     7 item DASS Anxiety   0.79     0.77 
     7 item DASS Stress   0.86     0.88 
     7 item DASS Depression   0.85     0.88 
6 Item SF12v2 Mental Component    0.82     0.85  
6 Item SF12v2 Physical Component  0.85     0.88 
8 Item FSSQ     0.89     0.91 
Note:  DASS = Depression, Anxiety, and Stress Scale. CQLQ= Cough Quality of Life 
Questionnaire. FSSQ =  Duke-UNC Functional Social Support Questionnaire. 
 
 To establish concurrent validity for the CQLQ, the baseline CQLQ total score was 
correlated with the baseline SF12v2 Physical Component Summary and the Mental Component 
Summary scores.  Using Fisher’s Measure of Skewness the SF12v2 scores, the physical 
component summary was found to be significantly skewed ranging from -2.79 to -3.58. The non 
parametric Spearman’s Rho Correlations demonstrated significant and moderate negative 
relationships between the CQLQ total score (lower scores indicate better quality-of-life) and both 
the Physical and Mental Component Summary scores of the SF12v2 (higher scores indicate 
better quality-of-life) (see Table 8).   
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Table 8 
Spearman’s Rho Correlations Between Baseline and 3 Month Cough-Specific Quality-of-Life 
and SF12v2 Physical Component Summary and Mental Health Component Summary 
                              Cough-Specific Quality-of-Life 
             Baseline    3 Months 
Baseline SF12v2 
 Physical Component Summary          -.482**    
 Mental Health Component Summary          -.325** 
3 Months SF12v2  
 Physical Component Summary       -.518** 
 Mental Health Component Summary       -.415**   
Note. ** Significant at the 0.01 level (2-tailed) 
 
Specific aim #1:  DASS scores were evaluated to determine if there was a change in 
psychologic factors (symptoms of depression, anxiety, and stress) from baseline to 3 months post 
standardized treatment for chronic cough. Mean signed rank scores were significantly reduced, 
reflecting improvement in psychologic symptom scores, for the DASS total score (p = .000), 
depression (p= .005), anxiety (p= .000), and stress (p= .000) subscales. Baseline scores and 3 
month post treatment scores for symptoms of depression, stress, and anxiety were on the lower 
end of the scale as reflected in Table 9.  Mann-Whitney U demonstrated no significant difference 
in any of the psychologic symptom scores based on the use or non-use of bronchodilators, 
antihistamines, or decongestants at baseline or 3 months post treatment.   
Table 9 
 
Baseline and 3 Month Mean Scores for Psychologic Factors   
                                    M(SD) Baseline (N=80) Mdn          M(SD) 3 Months (n=65) Mdn 
Psychologic Factors 
 DASS total        26.65 (21.33) 22.00                18.46 (18.54)         12.00 
DASS depression         6.60   (7.06)   4.00                4.77   (6.67)           2.00 
 DASS anxiety         8.60   (8.13)   6.00                5.72   (6.40)           2.00 
 DASS stress        11.45  (9.01)   9.01                7.97   (8.36)           6.00 
Note:  Lower scores reflect improvement for all scales.  Total score range = 0-126; subscale 
range = 0-42. M(SD)=  mean (standard deviation), Mdn=median.  
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The situational factor, represented by the FSSQ social support total score, was 
statistically assessed in the same manner as the psychologic factors as they too were found to be 
significantly skewed at baseline (-2.56).   No significant change was identified between baseline 
and 3 months post treatment values for social support (p=.087). 
Of the initial 80 subjects, 53 (66.3%) reported taking antidepressant medications and 6 
(7.5%) reported taking an anxiolytic drug.   Mann Whitney U Test revealed significant 
differences, with those taking antidepressants scoring higher than those who were not taking 
them, for the DASS total score (p=.008), anxiety subscale score (p=.007), and the depression 
subscale score (p=.024), but not for the stress subscale score.  Three months post treatment, the 
same analyses revealed that for the 52 subject where these data were available 17 (32.56%) 
reported taking antidepressants. Of these,  there were significant differences with those taking 
antidepressants scoring higher vs. those who were not for the DASS 3 month post treatment total 
score (p=.044) and stress subscale score (p=.031).   No significant differences were found in any 
DASS scores for those taking anxiolytic medications vs. those not taking them at baseline (n=6) 
or at 3 months post treatment (n=5).  Paired t-tests found that those taking antidepressants at 
baseline (M=68.73, SD=8.74) had significantly worse cough-specific quality-of-life scores 
compared to those not taking them (M=61.55, SD=15.26) (M=-7.18, SEM=.2.80, t(65.45) = -
2.56, p=.013) and no significant difference in cough severity scores at baseline.  At 3 months 
post treatment, paired t-tests demonstrated no significant difference in either cough severity or 
cough-specific quality-of-life for those taking vs. those not taking antidepressants.  Additionally, 
using the Mann Whitney U Test, no significant difference was found at baseline in FSSQ social 
support scores for those taking vs. those not taking antidepressants.   
Hypothesis #1.  To evaluate the associated hypothesis, that treatment of chronic cough using 
the ACCP guidelines will result in improvement in cough severity and cough-specific quality-of-
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life, paired t-tests conducted revealed significant improvement in cough severity 3 post months 
post treatment (M=2.32, (SEM =.291), t(64) =7.98, p=.000).  Second, cough-specific quality-of-
life, measured using the CQLQ, significantly improved (M=9.17, (SEM=1.30), t(64) =7.02, 
p=.000).  See Table 10 for baseline and 3 month mean scores 
Additionally, physiologic factors, represented by urge-to-cough and ability to speak being 
bothered by cough, measured using Punum Ladders, were assessed for change at 3 months. 
Scores were significantly improved for urge-to-cough (M=1.85, (SEM=0.29), t(64) =6.38, 
p=.000) and ability to speak being bothered by cough (M=2.15, (SEM=0.29), t(64) =7.38, 
p=.000) at 3 months.     
Table 10 
Paired T-test of Baseline and 3 Month Mean Scores for Symptom, Physiologic Factors and 
Cough-Specific Quality-of-Life   
                        M(SD) Baseline         M(SD) 3 Months                p  
Symptom 
Cough severity             6.11  (2.20)  3.78  (2.73)  .000 
Physiologic Factors 
 Urge-to-cough              5.77  (2.45)  3.92  (2.75)  .000 
Ability to speak             4.94  (2.99)  2.78  (2.59)  .000 
Cough-specific quality-of-life  
 CQLQ Total Score            63.68(13.97)            54.50(14.37)  .000 
Note:  Lower scores reflect improvement for all scales.  CQLQ= Cough Quality of Life 
Questionnaire (range 28-112).  Range for all physiologic factors and symptom 0-10. M(SD)=  
mean (standard deviation)  
 
The Related Samples Wilcoxon Signed Rank Test mean signed rank scores, evaluating 
change from baseline to 3 months, for SF12v2 Physical Component and the Mental Component 
Summary scores were significantly increased.  Table 11 contains the SF12v2 Physical and 
Mental Component Summary and individual Mental Component variable baseline and 3 month 
post treatment mean scores.  This increase reflects improvement in quality-of-life for the 
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Physical Component Summary (p=.001).  The minor increase in the Mental Health Component 
score was not significant (p=.209).    
Table 11 
 
Baseline and 3 Months Post Treatment SF12v2 Physical and Mental Health Component 
Summary Scores and Mental Health Variable Scores    
                      M(SEM) Baseline        M(SEM) 3 Months  
SF12v2  
    Physical Components Summary           45.80(1.11)  48.64(1.17) 
    Mental Components Summary         49.22(0.97)  49.72(1.07) 
 Accomplished less            4.16(0.11)    4.12(0.13) 
 Less careful             4.38(0.10)    4.40(0.11) 
 Peaceful             2.79(0.11)    2.72(0.11)* 
 Depressed/downhearted           4.28(0.09)    4.34(0.10)   
 Social time             4.06(0.11)    4.46(0.11) 
 Energy              3.09(0.11)    2.98(0.12)* 
Note:  * = reverse scored item where higher scores mean worse quality-of-life, for all others 
higher scores indicate better quality-of-life.  M(SEM) =mean (standard error of the mean). 
 
Specific aim #2:  To determine the relationship between baseline cough severity, cough-
specific quality-of-life, urinary incontinence, financial strain, employment, self prescribed 
medications, gender, marital status and education various statistical tests were conducted.  
Spearman’s Rho correlations (see Table 12) found urinary incontinence to be weakly (r = .231) 
related to cough severity, while a strong correlation (r=.612) was found with urinary 
incontinence and cough-specific quality-of-life.   Cough duration and age were not found to be 
related to cough severity or cough-specific quality-of-life. 
 To better understand the relationship of urinary incontinence to cough-specific quality-
of-life an independent t-test was conducted.  As expected, there was a significant difference by 
gender, with woman (M = 2.44, SD = 1.03) having worse urinary incontinence than males 
(M=1.40, SD =.707), (M= -1.04, SEM=.198, t(65.64) = -5.22, p=.000). 
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Table 12 
 
Spearman’s Rho Correlations for Baseline Cough Severity and Selected Continuous Baseline 
Variables (N=80) 
                     Baseline 
       Cough-Specific Quality-of-Life        Cough Severity 
  
Urinary Incontinence   .612**       .231* 
Cough Duration   .122      .048 
Age     .012            .124 
Note. *Significant at the 0.05 level (2-tailed).  ** Significant at the 0.01 level (2-tailed).    
  
No significant difference in cough severity scores was detected by gender (p=0.17), 
marital status (p=0.53), highest level of education achieved (p=0.12), use of self prescribed 
remedies (p = .06), or employment status (p = .36).  However, subjects who experienced some 
financial strain (M = 6.95, SD = 1.85) had significantly higher cough severity scores compared 
with those who had no financial strain (M = 5.81, SD =2.27), (M=1.14 SEM=.553, t(78) = 2.06, p 
= .043).    
Additionally, there was no significant difference in cough-specific quality-of-life scores 
by marital status (p=.50), highest level of education achieved (p= .10), and employment (p=.85).  
Again, those subjects who experienced some financial strain had worse scores (M = 69.05, SD 
=9.95) compared to those who had no financial strain (M = 62.03, SD =14.60), t(78) =2.035, 
p=.045).   Moreover, females were found to have worse cough-specific quality-of-life scores (M 
= 67.27, SD =12.61) than males (M = 56.40, SD =13.68), t(78) =-3.48, p=.001).  Also, those who 
used self prescribed remedies also has worse cough-specific quality-of-life scores (M = 66.90, 
SD =13.35) than those who did not use them (M = 54.80, SD =11.21), t(78) =-3.64, p=.000).     
Specific aim #3:  To determine the influence of physiologic factors (ability to speak 
without coughing, urge- to-cough and number of diagnoses), situational factors (social support), 
and psychologic factors (symptoms of depression, anxiety, and stress) on cough-specific quality-
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of-life and cough severity (global symptom/cough measure of timing, intensity, distress, and 
quality) at baseline and at 3 months post standardized treatment various statistical tests were 
conducted.   
These statistical analyses also addressed hypothesis # 2, that the physiologic factors 
(ability to speak without coughing, urge- to-cough and number of diagnoses), situational factors 
(social support), and psychologic factors (symptoms of depression, anxiety, and stress) predict 
cough severity (timing, intensity, distress, and quality); and hypothesis #3 that cough severity 
(timing, intensity, distress and quality) predicts cough-specific quality-of-life, that collectively if 
improvements are found in cough severity and cough-specific quality-of-life they will result in 
improvements in psychological factors, physical factors, and situational factors. 
Table 13 demonstrates that the baseline and 3 month post treatment scores for the 
physiologic and psychologic factors were significantly related to baseline cough-specific quality-
of-life and baseline cough severity. However, the situational factor of social support was not 
related to either variable at baseline or at 3 months post treatment.  Additionally, not shown in 
this table, the symptom of baseline cough severity was found to be significantly related to cough-
specific quality-of-life at baseline (r=.450, p=.01).  Also, not shown in this table, baseline urge-
to-cough was found to be significantly related to all psychologic factors (r= 315 to .405; p 
>=.01) as was ability to speak being bothered by cough (r= 259; p =.05 to 398; p =.01).  At 3 
months post treatment, the physiologic factor of number of diagnoses was not found to be related 
to cough severity or cough-specific quality-of-life. 
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Table 13 
Spearman’s Rho Correlations Between Baseline and 3 Month Post Treatment Physiologic, 
Situational and Psychologic Factors and Baseline Cough-Specific Quality-of-Life and Cough 
Severity 
                  Cough-Specific Quality-of-Life    Cough Severity   
Baseline Physiologic 
 Urge-to-cough    .360**    .643** 
 Ability to speak   .469**    .674** 
 # of diagnoses   
Baseline Situational  
 FSSQ social support  -.126     -.085 
Baseline Psychologic  
 DASS total    .572**    .414** 
 DASS anxiety    .507**    .419** 
 DASS stress    .484**    .323** 
 DASS depression   .512**    .356** 
3 Month Physiologic Factors 
Urge-to-cough    .291*     .501**   
Ability to speak   .261*     .524** 
 # of Diagnoses   .136     .036 
3 Month Situational Factors  
FSSQ total score  -.106                          -.162 
3 Month Psychologic Factors 
 DASS total    .435**    .487**  
 DASS anxiety    .356**    .486** 
 DASS stress    .431**    .414** 
DASS depression   .377**    .413**   
Note. *Significant at the 0.05 level (2-tailed).  ** Significant at the 0.01 level (2-tailed).    
 
Additionally, using ANOVA to compare the effect of the unadjusted associations 
between the continuous dependent variable cough severity and the independent categorical 
variables of self prescribed therapy, gender, employment marital status, and education (see Table 
14) no significant associations were found.   When adjusting for financial strain, a significant 
association was found (p = .043), with those experiencing financial strain having higher or worse 
cough severity scores than those who are not experiencing financial strain.   
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Table 14 
 
ANOVA Comparing Effects of Independent Sociodemographic Categorical Variables (N=80) on 
Cough Severity at Baseline 
                                     Cough Severity   
            M (SEM)      p 
 
Self Prescribed Therapy    -1.083 (.564)  .058 
Gender                  -.745  (.533)  .166 
Employment         .473  (.517)  .364 
Marital Status       -.333  (.527)  .529 
Education        .825  (.531)  .124     
Financial Strain       1.139  (.553)  .043* 
Note. *Significant at the 0.05 level.  Subjects were 97.8% white therefore associations were not 
assessed for race or ethnicity.  M(SEM) =mean (standard error of the mean). 
 
Similar analyses were conducted for the continuous dependent variable cough-specific 
quality-of-life.  Results suggested that women, those experiencing financial strain and subjects 
taking self-prescribed therapy had worse cough-specific quality-of-life (see Table 15).    
Table 15 
ANOVA Comparing Effects of Independent Sociodemographic Categorical Variables on Cough-
Specific Quality-of-Life (N=80) at Baseline 
                            Cough-Specific Quality-of-Life    
              M (SEM)                    p 
 
Self Prescribed Therapy -12.100 (3.322)      .000* 
Gender   -10.873 (3.123)   .001* 
Employment        -.615 (3.236)   .850 
Marital Status      -2.201(3.281)   .504 
Education       5.476(3.299)   .101    
Financial Strain        7.014(3.446)   .045* 
Note. *Significant at the 0.05 level.  Subjects were 97.8% white, therefore associations were not 
assessed for race or ethnicity. M(SEM) =mean (standard error of the mean). 
  
Specific aim #4:  A process for measuring intervention fidelity in the application of the 
ACCP guidelines for treating cough using the Technology Model was described in Chapter 3. 
Intervention fidelity was measured using (a) direct observations of care delivery of 15% of 
encounters using an observer checklist with, (b) completion of an intervention receipt form by all 
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subjects, and (3) review of the electronic medical record for concordance of subject and 
physician agreement of diagnoses and care.  The visits for direct observation were selected by 
random assignment using a random numbers list generated by SPSS 21.  Of the 12 planned 
observations only 11 were completed as 1 follow-up subject did not return for care.  This 11 
included the replacement of an additional subject who did not return for care by selecting the 
next random number.  The observations included 6 initial evaluations and 5 follow-up visits.   
 Table 16 provides the checklist that the PI observer used to rate intervention fidelity 
during the observed visits.  The level of  intervention fidelity to the study plan was observed 
during all observed visits was very high with regards to the application of the core diagnostic and 
management elements of the 2006 ACCP guidelines.  Using a 7 item checklist subject-physician 
fidelity to the implementation of the guidelines was very high with a mean score of 20.9 
(SD=.09), with the possible range being 0-14 and 14 representing the highest fidelity. 
Table 16 
 
Direct Observation of Intervention Fidelity Monitoring 7 item Observation Checklist (n=11)  
Variable         0         1      2          3 
                      n (%)       n (%)         n (%)       n (%) 
1. Was treatment prescribed according to           11 (100) 
    the guideline? 
2. Did the physician probe for patient    1(9.1)      10 (90.9)  
    understanding? 
3. Did the physician probe for patient           11 (100) 
    response (including cough severity 
    at baseline) and compliance? 
4. Did the physician maintain treatment           11 (100)  
    if indicated? 
5.  Did the physician step-up treatment           11 (100) 
     if indicated? 
6.  Did the physician order further             11 (100) 
     testing if indicated? 
7. Was follow up arranged?             11 (100)  
Note. IF= Intervention fidelity.   0=none; 1=low level of IF (addressed 2 or less); 2= moderate 
level of IF addressed 3; 3 high level of IF addressed all 4.   Range 0-21 (21= highest fidelity). 
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Results related to the electronic medical record review revealed that the cough severity 
rating was only documented for 22 (27.5%) of 80 initial subjects (see Table 17).  Moreover, 
Table 17 demonstrates that only 43 (53.8%) of the initial 80 subjects had a follow-up visit 
booked within 4-6 weeks.  
Table 17 
 
Dose: Visits booked (N=80)  
Variable              First Visit            Second Visit 
       n (%)       n (%)    
No visit booked      2   (2.5)      7   (8.8) 
4-6 weeks     43 (53.8)    18 (22.5) 
2-3 months     22 (27.5)    16 (20.0) 
4-6 months       7   (8.8)    10 (12.5) 
More than 6 months           2   (2.5) 
Booked 3 months moved to 4 weeks    1   (1.3) 
Did not return       5   (6.3)*     24 (30.0)* 
No visit booked, called for sick visit    2   (2.5) 
Cough resolved, follow-up not needed   1   (1.3)  
Note.  *unable to do electronic medical record review on 5 subjects included as they withdrew 
from the study 
 
Completion of an Intervention Receipt Form by the Subject 
 
Subject receipt of the interventions prescribed by the cough specialist for chronic cough 
was measured using the Intervention Fidelity Monitoring Questionnaire for Subject Receipt 
Evaluation described in Chapter 3. This form was adapted from a form previously developed for 
use in a pediatric intervention study (Bova & Sullivan-Bolyai).  Internal consistency reliability 
was excellent with a Cronbach’s alpha of 0.84 for the 7-item checklist.  The 7-item self report 
checklist that was part of this questionnaire resulted in subjects rating fidelity to the application 
of the guidelines as high with a mean score of 10.6 (SD=3.45) out of a possible 0-14 with 14 
being equivalent to the highest fidelity. 
Data were collected 3 months post initiation of the cough specialists’ prescribed 
treatment (see Table 18).   Of those completing the 3 month data collection (n=65), the majority 
 84 
of subjects were advised about the reason, response, side effects and length of treatment and the 
need for follow-up.  However, fewer than half of the subjects were told about additional 
treatments if cough remained a problem or the possible need for further testing.   
At the time of the 3 month data collection only 24 (30%) of the 65 responding subjects 
reported closely following their cough specialists’ instructions all of the time.  Of these 65 
subjects 35 (43.8%) reported following their cough specialists’ instructions most of the time and 
6 (7.5%) reported only following instruction some of the time.    
An additional question asked what treatment recommendations were not followed and 
why?  Thirty four (52.3%) of the 65 study subjects offered a comment regarding a 
recommendation not followed and why it was not followed.  Analysis of this open-ended 
question revealed that subjects who do not closely follow the cough specialists’ instructions have 
a variety of problems associated with prescribed treatments and many have more than one issue 
with treatment.  These problems with prescribed treatments include cost, side effects, feeling the 
treatment was not useful, and ability to incorporate treatment into one’s lifestyle.  
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Table 18 
 
Intervention Fidelity Monitoring 7 item Questionnaire for Participant Receipt Evaluation at 3 
Months Post Treatment for Chronic Cough (n=65)  
Variable        0        1       2  
          n (%)      n (%)   n (%) 
1. Advised you of the reason for      7(10.8) 58 (89.2)  
     prescribing treatment to manage 
     chronic cough 
2. Ask about your response to treatment 10 (15.4) 10 (15.4) 45 (69.2) 
3. Ask about side effects of treatment   9 (13.8) 13 (20.0) 43 (66.2) 
4. Talk about the length of time you   10 (15.4) 15 (23.1) 40 (61.5) 
     would need to continue to use the  
     treatment. 
5. Talk about the need for additional  13(20.0) 23 (35.4) 29 (44.6) 
     treatment if cough is still a problem 
6.  Talk about the need for further testing 19(29.2) 17 (26.2) 29 (44.6) 
      if cough is still a problem 
7. Was follow up arranged?     1  (1.5)   9 (13.9) 55 (84.6)  
Note. 0=not covered did not give any information; 1=covered somewhat would have liked more 
information; 2=covered completely; given all the information needed.  Range 0-14 (14=highest 
fidelity). 
 
Electronic Medical Record Review and Establishing Subject and Cough Specialist 
Concordance 
 
Subjects’ responses on the intervention receipt questionnaire, that included checking off 
or writing in diagnoses made and treatments recommended, were compared to data documented 
in the electronic medical record and rated for concordance of understanding by the PI.  The focus 
of the concordance rating was on the subject and cough specialist both documenting the same or 
similar diagnoses and treatments.   Investigator rating of subject-physician concordance of 
understanding of the implementation of the guidelines was found to be high with 83.1% in 
complete or almost complete agreement (see Table 19).  
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Table 19 
 
Concordance with of Participant Receipt and EMR Documented Intervention Delivery Based on 
Chart Review at 3 Months Post Treatment for Chronic Cough (n=65)  
Variable    0        1       2   3 
                 n (%)      n (%)  n (%)            n (%) 
Concordance             1 (1.5)   10 (15.4)        24 (36.9)       30(46.2) 
Note.  0= No agreement; 1= somewhat agree; 2= almost complete agreement; 3 complete 
agreement.  
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CHAPTER 5 
Discussion 
 This chapter discusses changes in psychologic factors at 3 months post treatment with the 
ACCP cough management guidelines; the relationships between baseline cough severity and 
cough-specific quality-of life and demographic factors; and the influence of physiologic, 
psychologic, and situational factors on cough severity and cough-specific quality-of-life at 
baseline and 3 months post treatment.  Additionally, this chapter provides empiric support for the 
Theory of Unpleasant Symptoms and the measurement of intervention fidelity in the application 
of the ACCP guidelines.  Chapter 5 concludes with study limitations, conclusions, implications 
for research and practice.   
The need to employ the use of valid outcome measures when assessing the impact of 
treatments for chronic cough is noted by the ACCP guidelines (Irwin, 2006a).  The Punum 
Ladders used in this study, were supported as both a reliable and valid outcome tools based upon 
strong test-retest correlations and the fact that cough severity, urge-to-cough, and ability to speak 
being bother by cough improved as post treatment cough severity and cough quality of life 
simultaneously improved.  Concurrent and construct validity for the CQLQ were demonstrated 
as cough severity was significantly related to cough-specific quality-of-life and as cough severity 
improved, improvements were also found in cough-specific quality-of-life.  The CQLQ was 
further supported as a valid measure of quality-of-life, in that concurrent validity was 
demonstrated with the total CQLQ score being significantly related to the SF12v2 mental and 
physical scales. Moreover, the post treatment scores of the CQLQ and SF12v2 physical scores 
simultaneously significantly improved, also supporting the validity of the CQLQ as a valid 
measure of quality-of-life.  
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Change in Psychologic Factors at 3 Months Post Treatment 
In this study, whose primary purpose was to describe changes in the symptoms of 
depression, anxiety, and stress in adults with chronic cough after treatment using the ACCP 
guidelines, the population was composed of predominately white middle aged non-smoking 
adults presenting to a cough specialty clinic with a long standing severe cough.  In this 
population, all psychologic symptom scores were significantly reduced and within the normal 
range, based upon established norms, at 3 months post treatment with the guidelines.  Baseline 
depression and stress symptom scores in this group were found to be within the normal severity 
range, based upon a normative sample of 1044 males and 1870 females that were 17-69 years of 
age (S. H. Lovibond & P. F. Lovibond, 1995). Based on the same normative sample, the baseline 
anxiety symptom scores were found to be within the mild severity range (S. H. Lovibond & P. F. 
Lovibond, 1995).   Despite being within or close to the normal range this study demonstrated 
that, in those with chronic cough, all of these symptoms could be further reduced with treatment 
of the chronic cough using the ACCP guidelines. 
Relationships with Demographic Factors 
While not proposed by this study as situational factors, the Theory of Unpleasant 
Symptoms does propose demographic factors, such as financial strain and gender, as situational 
factors that can influence the symptom experience (A. Gift, 2009).  In this study, cough severity 
was found to be more severe in those who had financial strain compared to those who did not 
have financial strain.  In contrast, the negative effects of chronic cough on cough-specific 
quality-of-life were found to be significantly greater in those with financial strain, of female 
gender, and in those who used self-prescribed remedies. The difference in the findings of female 
gender likely relate to the problem with urinary incontinence and while a physical problem, this 
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may have a negative impact on psychologic factors (C. T. French et al., 2004).   In the population 
studied, 75% of subjects noted at baseline that they used a self prescribed remedy.  It is possible 
that the use of self prescribed remedies is the result of poor cough-specific quality-of life.  This 
finding would be consistent with the feedback mechanism described by the Theory of 
Unpleasant Symptoms, in that an alteration of a situational factor may result from the 
consequences of a symptom on quality-of-life (A. Gift, 2009; Lenz & Pugh, 2008; Lenz et al., 
1997).    
Influence of Physiologic, Psychologic and Situational Influencing Factors 
This study lends empiric support to the Theory of Unpleasant symptoms in that these 
psychologic factors were significantly related to the symptom of chronic cough and cough-
specific quality-of-life, and they improved as these two outcome variables improved (Lenz et al., 
1997).  Similar findings were noted with the physiologic factors.  Both urge-to-cough and ability 
to speak being bothered by cough were also found to be significantly related to cough severity 
and cough-specific quality-of-life and again both improved as the outcome variables improved.  
At the same time the physiologic factor of number of diagnoses and the situational factor of 
social support were not found to be related to either cough severity or cough-specific quality-of-
life.  While social support was measured in this study, no social support interventions were 
offered.  Higher levels of social support have been identified by others as being related to better 
physical and emotional health (Broadhead et al., 1983; Powers et al., 2004).  During the 
development of the CQLQ subject interviews revealed that family and friends could often not 
tolerate the cough any more (C. L. French et al., 1998; C. T. French et al., 2002).  This finding 
indicates that it is possible that social support is not offered as willingly by friends and family 
and the need for social support may be an issue for those with chronic cough.  Additionally, with 
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the median duration of the chronic cough being 24 months and the  post treatment timeframe for 
measuring follow-up social support being 3 months, this may be too short a timeframe for any 
change in social support related to improved chronic cough to be realized.  Also, there could be a 
ceiling affect with the tool used to measure social support as initial scores were high.  Finally, 
the population in this study was primarily well educated, white, employed individuals with no 
reported financial strain and consulting in a highly specialized cough clinic may not be 
representative of the general chronic cough population as it pertains to this issue. 
Number of diagnoses was included as a physiologic factor in this study as it was assumed 
that the more diagnoses a patient had the more complex the symptom experience would be.  No 
relationship was found with number of diagnoses and cough severity or cough-specific quality-
of-life.  In this study, as demonstrated in other studies (Irwin, Corrao, & Pratter, 1981; Ribeiro, 
De Castro Pereira, Nery, Beppu, & Silva, 2006), the use of the ACCP guidelines was associated 
with improvement in cough supporting the accuracy of the diagnoses.  The most common 
diagnoses identified were gastroesophageal reflux disease, upper airway cough syndrome, and 
asthma, as is consistent with the findings of others (Pratter, 2006b; Ribeiro et al., 2006).   Also, 
consistent with the findings of others, more than one condition was often simultaneously 
identified as causing cough (Pratter, 2006b).  Others have reported anger in patients with chronic 
cough and distress related to frequent physician visits (Kuzniar et al., 2007), suggesting that 
outlining the extended plan for care necessary to address the multiple causes early on may be 
important.  Because, it seems intuitive that the more diagnoses, the more complex the treatment 
and the more difficult it would be to comply with a complex treatment plan, this area is worthy 
of further study. 
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Empiric Support for the Theory of Unpleasant Symptoms 
This study provides empiric support for the Theory of Unpleasant Symptoms in that, core 
symptoms reflective of the psychologic factors of depression, anxiety, and stress were found to 
be related to cough severity.  Cough severity was found to be related to cough-specific quality-
of-life.  Both of these variables improved in association with the use of the ACCP guidelines for 
management of cough as did the symptoms of depression, anxiety, and stress (psychologic 
factors), suggesting the presence of the feedback mechanism proposed by the theory.  Moreover, 
the consequences of cough severity, as reflected by the items of the CQLQ (the theory surrogate 
for performance), help us understand why symptoms of depression, anxiety, and stress may co-
exist with chronic cough and why they improve as cough improves.  The CQLQ individual items 
reveal that those with chronic cough often suffer from many chronic cough induced problematic 
effects on their quality of life.  These problems include embarrassment, feeling self-conscious, 
the need to avoid social activities, feeling upset that people feel something is wrong with them, 
the fear of tuberculosis or cancer, the need for reassurance that nothing is seriously wrong, 
feeling family can’t tolerate it anymore and other issues.  Intuitively as chronic cough resolves, 
and as suggested by this study, its negative impact on cough-specific quality-of-life, the 
individual problems described by the CQLQ, and any associated psychologic distress would be 
ameliorated.  These findings support the feedback mechanism suggested by the theory (Lenz & 
Pugh, 2008).   
Findings of this study also support the theory’s assumption that the presence of more than 
one symptom can result in the symptoms catalyzing each other resulting in a multiplicative effect 
on the consequences of the symptom experience expressed as quality-of-life (Lenz & Pugh, 
2008; Lenz et al., 1997).  This is demonstrated in that baseline cough severity was not found to 
differ significantly by gender, yet cough-specific quality-of-life did differ by gender with 
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females having worse scores. The population studied had more females than males as is common 
in studies of those with chronic cough (C. T. French et al., 2004; Kelsall et al., 2009) and urinary 
incontinence was found to be a significantly greater problem for females, as has been found in 
past studies (C. T. French et al., 2004).  Urinary incontinence was found to have weak but 
significant and positive relationship with cough severity. In contrast, with regards to cough-
specific quality-of-life, urinary incontinence was found to have a moderately positive and strong 
significant relationship.  This finding would support the assumption of the theory in that urinary 
incontinence may be less a physiologic factor influencing the symptom experience, and more an 
additional symptom that adds to the impact of the symptom of chronic cough on cough-specific 
quality-of-life (Lenz & Pugh, 2008; Lenz et al., 1997).   
Additionally, those taking antidepressants had worse total psychologic factor and 
depression and anxiety symptom scores.  Simultaneously, cough-specific quality-of-life was 
worse in those taking antidepressants at baseline but not cough severity; yet, 3 months post 
treatment for cough, there was no difference in either variable.  This suggests that psychologic 
factors are likely influenced by the consequences of the impact of cough on cough-specific 
quality-of-life and that when cough improves so do the psychologic symptoms.  This finding 
supports the assumption that the outcome of the symptom experience, as reflected by cough-
specific quality-of-life, likely feeds back to the psychologic factors. It also suggests that the 
psychological symptoms of our subjects when initially seen would have been worse had they not 
been on antidepressants and anxiolytics. 
Intervention Fidelity to the Study Plan 
We are not aware of any prior study addressing the issue of intervention fidelity as it 
relates to the diagnosis and management of chronic cough using established guidelines.  
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Measuring intervention fidelity is important to establish the validity of an interventions effect 
(Bellg et al., 2004; Santacroce et al., 2004).   Fidelity to the treatment protocols is important as 
the diagnosis of a cause of chronic cough is dependent upon response to specific treatment and 
because the cough guidelines advise that the diagnosis of unexplained chronic cough only be 
used after failure of guideline protocols (Pratter, 2006c).  While the observed physician 
evaluation and management visits were associated with very high fidelity, intervention fidelity 
could have been better.  Two of the original planned 12 visits did not occur. Both of these 
subjects were scheduled for their first follow-up outside of the 4-6 week timeframe 
recommended and did not return.  While there was very high fidelity in the observed visits, 
electronic medical record review revealed less than a quarter of the subjects had baseline cough 
severity rating documented as outlined in the intervention fidelity manual.  Additionally, the 
manual noted a plan for 4-6 week follow-up visits, yet record review revealed only just over half 
of the subjects had a 4-6 week follow-up booked.  Investigator ratings of concordance of subject-
physician understanding resulted in almost 50% being in complete agreement. More than 50% of 
subjects noted that the physician asking about response to treatment, side effects and follow-up 
had been completely covered.  Yet, less than 50% of subjects noted that the need for further 
treatment or testing if cough remains a problem had been completely addressed.   
Despite the high rates of fidelity and concordance reported in this study, at the 3 month 
data collection only (30%) of the subjects noted that they were closely following their physicians 
instructions. More than half of the subjects offered a reason they were not following the 
physicians recommendations including: side effects, cost, feeling the treatment was not useful, 
and difficulty incorporating treatment into one’s lifestyle 3 months post initiation of treatment. 
While reports of problematic side effects or other issues resulting secondary to treatment for 
chronic cough are sparse in the literature pertaining to the use of cough guidelines, our finding of 
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lack of adherence with prescribed treatment is consistent with that of Al–Mobeireek and 
associates (2002).  These investigators found that 23% of those with chronic persistent cough 
(N=100) stopped therapy during treatment.  The reasons for stopping therapy were not elaborated 
upon in this study, yet it was noted that cough only resolved after resuming therapy (Al-
Mobeireek et al., 2002).    
Limitations 
 Potential limitations of this study included the use of a non random sample drawn from 
one highly specialized cough clinic.  Because this cough specialty clinic attracts patients who 
have seen multiple other providers/specialists, the subjects may have reflected a different 
population of those with chronic cough than those seeing a specialist for the first time.  
Moreover, because 16 patients were not willing to enroll, this could have biased the findings so 
that the results are less likely to be generalized to the population of those with chronic cough at 
large.   
Of the initial 111 patients presenting to the Cough Clinic, 8 were excluded due to being 
unable to either speak or read English.  Of those unable to either speak or read English first 
languages included Spanish (n=5), Portuguese (n=1), Chinese (n=1), and Albanian (n=1). As is 
consistent with other studies of those with chronic cough the population in this study was 
predominately female (C. T. French et al., 2004).  Therefore the findings are limited in that they 
can only be generalized to the population studied and that is those who are English speaking, 
primarily white, middle aged, and predominately female.   
With regards to the monitoring of intervention fidelity it was recognized that by sitting in 
on visits the Hawthorne effect could have been induced adding a bias to this study.  While 
subject-physician concordance was measured by chart review, fidelity to the study plan 
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(guidelines) was not measured in this manner.  Additionally, the measurement of subject-
physician concordance was subjective and completed by a single investigator.  Electronic 
medical record review is a potential bias in that the information was not always in the same 
electronic location and it is dependent upon the information being accurately documented in the 
record. 
Implications for Research  
This study has several important implications for future research.  Financial strain, 
gender, and use of self prescribed remedies may have a role as situational factors that can 
influence cough-specific quality-of-life and are worthy of further study.  While social support 
was not found to be related to cough severity or cough-specific quality of life, this study did not 
provide any intervention that would specifically attempt to augment social support.  Moreover, 
the timeframe for this study may have been too short to see change, the tool used to measure 
social support may be subject to a ceiling effect, and/ or the population studied may not be 
representative of all those with chronic cough.  Because social support has known positive 
effects on physical and psychological health further study is warranted.  We also suggest that 
studies should include non-English speaking patients in their samples.  
Our findings suggest that the Theory of Unpleasant Symptoms may be useful in the study 
of chronic cough as it helps us to understand the complex relationships of factors that may 
influence cough severity and cough-specific quality-of-life. Furthermore, these findings help us 
understand the complexity of the management of chronic cough.  The findings noted in this 
manuscript stress the importance of measuring both cough severity and cough-specific quality-
of-life when trying to define the impact of the problem and the response to treatment.  Future 
research should further stratify the data based on varying levels of cough severity and or cough-
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specific quality-of-life to assess for the presence of subpopulations where psychologic factors 
may play a greater influencing role.   Additionally, longitudinal studies should be conducted to 
see if the findings of this study are sustained over time. 
This study highlights the importance of addressing intervention fidelity in research 
related to the management of chronic cough. Fidelity to guideline core elements by the subject 
and physician is important and it should be measured because it augments the validity of the 
results of the diagnostic workup and the outcome of specific treatment that will be prescribed.   
While observed visit intervention fidelity was very high, chart review demonstrated lack of 
fidelity in the area of documenting initial cough severity to provide a basis for future reference 
when trying to determine response to treatment and in scheduling a 4-6 week follow-up visit.  
Lack of fidelity in these 2 areas could be reflective of an overall lack of fidelity to the study plan 
that was not apparent during observed visits. Future research may benefit from other methods of 
measuring intervention fidelity such as post visit patient or physician interviews. While this 
study measured use of self prescribed remedies at baseline only, the fact that 75% were using 
self-prescribed remedies suggests the need to ask about these proscribed interventions at more 
than one time point for future studies.   Because, fidelity to the intervention is essential to valid 
conclusions about treatment outcomes, future studies of management strategies for chronic 
cough should include strategies to monitor and enhance intervention fidelity. 
This is the first study, that we are aware of, that used the DASS 21 to quantify 
psychologic symptoms in adult subjects with chronic cough.  When compared to an earlier pre 
and post intervention study that used a different scale for measuring psychological symptoms 
and that found different results (Dicpinigaitis et al., 2006), this study did not find the presence of 
more serious levels of psychologic symptoms in those with chronic cough.  The results of this 
earlier study that sought to establish the prevalence of depressive symptoms in those with 
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chronic cough using the Center for Epidemiologic Studies Depression Scale (CES-D),   
suggested that the patients with chronic cough had significant depressive symptomatology. None 
of the subjects in this group were reported to be taking antidepressants or as having a history of a 
diagnosis of depression (Dicpinigaitis et al., 2006).  However, the results of this study are 
difficult to interpret for the following reasons: the CES-D identifies a score of > 16 as the cut 
point signifying risk for depression and in this study while the mean was 18.6 (SD=13.4), the 
median was 16 and it was noted that the data were skewed making the median more reflective of 
the population studied (Dicpinigaitis et al., 2006).  Moreover, this study did not use a survey 
instrument that was designed to assess anxiety.  The DASS was chosen for our study as it was 
designed to define separate core symptoms of depression, anxiety, and stress that would allow 
for differentiation between the conditions (S. H. Lovibond & P. F. Lovibond, 1995).  Because, 
anxiety and depression share a component of general affective distress and have a potential 
overlap in symptomatology, it is possible that the CES-D scores reflected some component of 
anxiety.  In this study, as cough improved the CES-D scores also improved with the mean and 
median falling into the normal range (Dicpinigaitis et al., 2006).  Similarly, after treatment, in 
our study, all psychologic symptoms were lower.  Because some of our patients were taking 
antidepressants and anxiolytics, their use in those with chronic cough should be further explored. 
In a study that used the Hospital Anxiety and Depression Scale to assess the prevalence 
of psychomorbidity in those with chronic cough, the findings were similar to ours, in that the 
mean scores (N=57) for both anxiety and depression were found  to be in the normal range 
(McGarvey et al., 2006).  Similarly, our findings are similar to those found in chronic cough 
subjects unresponsive to medical management by Vertigan and Gibson (2011) where anxiety and 
depression symptom scores, measured using the Hospital Anxiety and Depression Scale, were 
also found to be within the range of normal.  In our study the DASS scores for anxiety fell within 
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the mild category indicating to us that the DASS may indeed be strongly discriminative in its 
ability to assess symptoms of anxiety and depression.  Because depression and anxiety 
commonly co-occur in patients seeking care in the primary care setting (Hirschfeld, 2001), it is 
important to differentiate between the two conditions. 
Implications for Practice 
This study has identified a number of issues related to clinical practice.   Depression, 
anxiety, and stress symptoms should be considered when counseling patients.  For example, it 
may be important to share the meaning of a negative chest x-ray as it relates to ruling out more 
serious causes of chronic cough.  Because those using self prescribed remedies, females, and 
those with financial strain have worse cough-specific quality-of-life, and because patients may 
be hesitant about sharing this information, we recommended that physicians incorporate a plan 
for asking about these issues as part of routine care of those with chronic cough.    
Qualitative review found that patients have problems following recommended treatment 
plans secondary to issues such as side effects, cost, not feeling the treatment is useful, and 
problems incorporating treatment into their lifestyle.  These findings suggest that scheduling a 4-
6 week follow-up visit is likely to be important, as it would allow for treatment plan adjustments 
in an effort to improve treatment adherence and successful management of chronic cough.  Also, 
the need for an extended treatment plan based upon the potential for multiple causes of chronic 
cough should be shared with patients at the onset of care.  Patients should be advised that the 
problem of chronic cough is complex and that we do have a systematic way of working through 
the issues with them but it will take time and multiple visits. 
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Conclusions 
 In conclusion, this study found that use of the ACCP guidelines for the management of 
chronic cough resulted in improved psychologic symptoms as cough severity and cough-specific 
quality-of-life.  Symptoms of depression, anxiety, and stress were of normal or near normal 
severity at baseline; yet, all of these psychologic factors were found to improve as cough severity 
and cough-specific quality-of-life improved.  The Theory of Unpleasant Symptoms has been 
useful in understanding these complex relationships of factors that influence chronic cough and 
these relationships should be further delineated in future studies.  There are multiple areas when 
fidelity to guideline core element implementation may be problematic for both patients and 
physicians.  Intervention fidelity to guideline core elements, by the subject and physician is 
important and it should be measured as an independent study variable, as a valid diagnosis of a 
cause of chronic cough is dependent upon response to specific treatment. 
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Appendix A 
Sociodemographic Questionnaire Baseline 
Date_________________________________      Collected in person, online, via postal mail (please 
circle one) 
Study number  
How would you prefer to be contacted for reminders and follow-up data collection (please circle 
and complete those that apply to you) 
 Phone (please provide preferred number):                                
 Email (please provide preferred email address):                                                    
 Postal mail (please provide preferred address) :                                                                            
                                                                                                                                                       
 Please indicate the day(s) of the week that might work best for you to be contacted by circling 
one or more Monday, Tuesday, Wednesday, Thursday, Friday, Saturday, Sunday 
 Please indicate the time of day that might work best for you to be contacted AM or PM (please 
circle one) 
How many months have you been coughing (enter number of months)? 
Age (in years) 
Do you use over the counter or self prescribed or home remedies to treat your cough (circle one)? 
Yes / No 
If yes please list type 
Over the counter self prescribed cough medicine 
Honey 
Zinc 
Echinacea 
Mucinex (Guaifenesin) 
Robitussin 
Cough drops 
Herbal Supplements 
Neti Pot 
Other please list 
 
 
Gender (circle one) 
 Male / Female 
Race (circle one) 
 White / American Indian and Alaska Native / Asian / Black or African American / Native Hawaiian 
/ Other Pacific Islander 
Ethnicity (circle one) 
 Hispanic or Latino / Not Hispanic or Latino 
Marital status (circle one) 
 Single / Married / Widowed / Divorced 
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Currently Employed (circle one) 
Yes / No 
For those answering yes please check off type of employment 
Clerical 
Administrative 
Management 
Public Service 
Teacher 
Lawyer 
Other 
 
Highest level of education completed (circle one) 
 Less than high school 
 High School 
 College 
 Graduate School 
How hard is it for you to pay for the very basics like food, housing, medical care, and heating? 
Would you say it is very hard, somewhat hard, or not very hard at all? 
 1    VERY HARD 
 2    SOMEWHAT HARD 
 3    NOT VERY HARD AT ALL 
 -8   DON'T KNOW 
 -7    REFUSED 
 
Is there anything else you would like share with us about your chronic cough experience? 
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Appendix B 
Cough Quality of Life Questionnaire 
NAME:                                                                                       STUDY RECORD #: DATE:
Please indicate below how your cough affects you.   Circle the answer that best describes your agreement with each 
item.   Please respond to every item.  Thank you for your help. 
1.  Family and or close friends can’t tolerate it any more.  STRONGLY DISAGREE DISAGREE AGREE STRONGLY AGREE
2.  I have experienced prolonged absences from STRONGLY DISAGREE DISAGREE AGREE STRONGLY AGREE 
important activities such as work, school, or 
volunteer services.
3.  I have been completely prevented from STRONGLY DISAGREE DISAGREE AGREE STRONGLY AGREE 
engaging in important activities such as work, 
school, or volunteer services.  
4.   I have lost my appetite. STRONGLY DISAGREE DISAGREE AGREE STRONGLY AGREE
5.  I am sick to my stomach and vomit. STRONGLY DISAGREE DISAGREE AGREE STRONGLY AGREE
6.  I cough and it makes me retch (dry heaves). STRONGLY DISAGREE DISAGREE AGREE STRONGLY AGREE
7.  I have a fear that I might have AIDS or STRONGLY DISAGREE DISAGREE AGREE STRONGLY AGREE 
tuberculosis.
8.  I have headaches. STRONGLY DISAGREE DISAGREE AGREE STRONGLY AGREE
9.  I am concerned that I have cancer. STRONGLY DISAGREE DISAGREE AGREE STRONGLY AGREE
10. I am dizzy. STRONGLY DISAGREE DISAGREE AGREE STRONGLY AGREE
11. I wet my pants. STRONGLY DISAGREE DISAGREE AGREE STRONGLY AGREE
12. I soil my pants. STRONGLY DISAGREE DISAGREE AGREE STRONGLY AGREE
13. I sweat. STRONGLY DISAGREE DISAGREE AGREE STRONGLY AGREE
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14. I am hoarse. STRONGLY DISAGREE DISAGREE AGREE STRONGLY AGREE
15. It hurts when I breathe. STRONGLY DISAGREE DISAGREE AGREE STRONGLY AGREE
16. I broke a rib. STRONGLY DISAGREE DISAGREE AGREE STRONGLY AGREE
17. I cannot sleep at night. STRONGLY DISAGREE DISAGREE AGREE STRONGLY AGREE
18. I have difficulty speaking on the phone. STRONGLY DISAGREE DISAGREE AGREE STRONGLY AGREE
19. I can no longer sing, for instance in church. STRONGLY DISAGREE DISAGREE AGREE STRONGLY AGREE
20. I have stopped going to social activities STRONGLY DISAGREE DISAGREE AGREE STRONGLY AGREE
such as movies, plays, town meetings.
21. I have had to change my lifestyle. STRONGLY DISAGREE DISAGREE AGREE STRONGLY AGREE
22. I ache all over. STRONGLY DISAGREE DISAGREE AGREE STRONGLY AGREE
23. I am exhausted. STRONGLY DISAGREE DISAGREE AGREE STRONGLY AGREE
24. I am embarrassed. STRONGLY DISAGREE DISAGREE AGREE STRONGLY AGREE
25. I am upset by people thinking that I have STRONGLY DISAGREE DISAGREE AGREE STRONGLY AGREE
something wrong with me.
26. I want to be reassured that I do not have STRONGLY DISAGREE DISAGREE AGREE STRONGLY AGREE 
anything  seriously the matter with me.
27. I am self conscious. STRONGLY DISAGREE DISAGREE AGREE STRONGLY AGREE
28. I am concerned that I have something STRONGLY DISAGREE DISAGREE AGREE STRONGLY AGREE 
seriously the matter with me.
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Appendix C 
Punum Ladders 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Please check the rung on the ladder that best describes th  
         
quality into account over the past week. 
e
severity of your cough taking timing, intensity, distress and 
Worst  
Possible 
Cough 
Very  
Severe 
Cough 
Severe  
Cough 
Moderate 
Cough 
Mild  
Cough 
No 
Cough 
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Please check the rung on the ladder that best describes your urge-to-
cough (feeling of need to cough whether you coughed or not) 
considering timing, intensity, distress and quality, over the past week. 
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Please check the rung on the ladder that best describes how 
much has your ability to speak considering timing, intensity, 
distress and quality, been bothered by cough over the past week? 
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Intervention Manual 
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Purpose of the Intervention Manual  
 
This manual has been developed to provide a guide for monitoring intervention fidelity in the 
application of the 2006 American College of Chest Physicians’ Diagnosis and Management of 
Cough: ACCP Evidence-Based Clinical Practice Guidelines in the study Examining Change in 
Depression, Anxiety, and Stress being conducted as the dissertation for the principal investigator 
Cynthia French. 
 
 
Purpose and Specific Aims of the Study 
 
The purpose of the study for which this manual has been developed is to describe changes in the 
symptoms of depression, anxiety, and stress in adults with chronic cough after management 
using the 2006 American College of Chest Physicians’ Diagnosis and Management of Cough: 
American College of Chest Physicians (ACCP) Evidence Based Clinical Practice Guidelines.   
 
The specific aims of the study are to:   
 
1. Describe the change in psychologic factors (symptoms of depression, anxiety, and 
stress) at 3 months after standardized treatment for chronic cough;  
2.  Describe the relationship between cough severity and urinary incontinence, financial 
strain, employment, number of diagnoses, ability to speak being bothered by cough, 
and social support score, DASS-21 subscale scores, and concordance with prescribed 
therapy score. 
3. Describe the influence of physiologic factors (ability to speak without coughing, 
urge- to-cough and number of diagnoses), situational factors (social support), and 
psychologic factors (symptoms of depression, anxiety, and stress) on cough-specific 
quality-of-life  and cough severity (global symptom/cough measure of timing, 
intensity, distress, and quality) at baseline and at 3 months post standardized 
treatment;  
4. Describe the process of measuring intervention fidelity in the application of the 
ACCP guidelines for managing cough using the Technology Model.   
 
 
This manual will specifically serve as a guide for the interventions employed in the application 
of the ACCP guidelines for managing cough as specified by specific aim number 4. 
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Flow diagram of the participants’ progress thorough the study 
 
 
 
Recruit Eligible Chronic Cough Patients
No, Declines ParticipationYes, Interested in the Study
Verify Eligibility & Informed Consent Procedures Collect reasons for decline (deidentify)
Not Eligible or no longer interested
Yes: Eligible Informed Consent Obtained
Phase 1: Baseline Data Collection
Intervention
Phase 4: 3month follow-up: collect final data
Phase 2: Collect 
2nd Punum 
Ladders
Phase 5: Chart review to rate concordance
Phase 3: 
Observed visits
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Intervention Overview and Standard of Care 
 
The intervention that is the focus of this study is the application of the 2006 American College of 
Chest Physicians’ Diagnosis and Management of Cough: American College of Chest Physicians 
(ACCP) Evidence Based Clinical Practice Guidelines.   The chronic cough management 
algorithm within these guidelines will serve as a primary focus for guiding the diagnosis and 
management of chronic cough. See Appendix A.  The entire guideline will provide the detail for 
recommendations for the diagnostic and management interventions to be employed in the 
management this symptom.  The use of these guidelines is the existing standard of care for 
interventions employed for those > 15 years of age seeking medical care for cough lasting > 8 
weeks in the cough specialty clinic located within the UMass Memorial Lung and Allergy Center 
on the University Campus.   
 
With regards to this study: 
 Research participants’ will attend a standard initial new patient evaluation and management 
physician visit for the primary problem of the symptom of chronic cough of  > 8 weeks 
duration 
 Initial and follow-up care will be based upon the 2006 ACCP diagnosis and management of 
cough guidelines as it is the existing standard for any patient visit within the cough specialty 
clinic.   
 Follow-up care may be delivered in person or via phone call as is also the standard in the 
cough specialty clinic.  Phone management is often employed in this clinic for any patient 
whose home location makes an in-person visit not feasible. 
 Research participant care will be managed by a physician and augmented by nurses, nurse 
practitioners, and nutritionists as is standard in the cough specialty clinic. 
 The data collection plan includes the principal investigator’s (PI) observation of 12 randomly 
captured intervention sessions. We will not be able to predict how many observations will 
be completed per physician due to random assignment. The PI will unobtrusively sit in on 
patient visits with interventionists who volunteer to have their visits monitored and the 
delivery of interventions rated.  The plan is to observe for consistency of application of the 
guidelines for the study; data will be deidentified study and complete interventionist 
confidentiality will be maintained. There will be no risk for the interventionist. The PI will 
complete the Intervention Fidelity Checklist after observing physician research participant 
visits. See Appendix B. 
 Data collected during interventionist / research participant interaction observations will be 
coded using deidentifed subject identification numbers and no data will be directly associated 
with the interventionist.  All data collected will be stored under deidentified study participant 
numbers; no data will be coded or stored based upon individual interventionist as this is not a 
study of individual interventionist intervention fidelity. 
 The PI will also collect receipt of intervention data from all research participants by asking 
them to complete self report questions developed to measure receipt of the intervention at the 
conclusion of the 3 month intervention period.  
 The PI will review the electronic medical record (Allscripts) and compare this to the self 
report of participant receipt of the intervention to assess for and rate the degree of 
concordance of intervention(s) prescribed and subject self report of receipt.  
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Roles of Interventionist and the Principal Investigator 
 
Interventionist:  The interventionist is the attending board certified pulmonology physician 
providing care for the research participant.  He/she has at least 5 years experience and skill in 
using the 2006 American College of Chest Physicians’ Diagnosis and Management of Cough: 
American College of Chest Physicians (ACCP) Evidence Based Clinical Practice Guidelines for 
managing chronic cough.  The interventionist is responsible for: 
 The safe and effective delivery of the interventions related to the diagnosis and management 
of chronic cough based upon the 2006 ACCP guidelines. 
 Maintaining fidelity of the intervention according to that recommended by the intervention 
manual as taken directly from the 2006 ACCP guidelines for the diagnosis and management 
of cough and within the context of the individual research participants’ medical situation. 
 Participating in debriefing sessions with the investigator no more often than every 3 months 
or until a collective total of 12 patient sessions across all interventionists have been 
monitored. 
 Conduct follow-up 4-6 weeks after the first visit. 
 
Study principal investigator: Provide technical educational information related to this study 
and/or support the interventionist during the study.  Specific study requirements to be carried out 
by the PI investigator include: 
 Meet with each interventionist to establish willingness to volunteer to participate in this 
study. 
 Orient interventionist to the intervention manual and its contents. 
 Observe and measure intervention fidelity interactions with the interventionists and research 
participants. 
 Offer interventionist debriefing sessions after the first 5 and then after the final 5 observed 
visits have been completed.   
 Ask all research participants to complete a questionnaire providing their perception of receipt 
of the intervention at the 3 month post intervention time period. See Appendix C. 
 Conduct a review of the electronic medical records (Allscripts EMR) and rate the degree of 
concordance between research participants self report of receipt and documented intervention 
prescribed. See Appendix D. 
 Deidentify, code, and store data. 
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Intervention: Initial Visit 
 
American College of Chest Physicians’ Diagnosis and Management of Cough: American 
College of Chest Physicians (ACCEPT) Evidence Based Clinical Practice Guidelines 
Chronic Cough Algorithm 
 
The algorithm for chronic cough (see Appendix A) systematically directs the interventionist in 
the assessment of the most common causes of chronic cough with the guidelines suggesting 
focused empiric treatment for each cause identified.  After screening for and eliminating 
smoking and the use of angiotensin converting enzyme inhibitors, and determining that the chest 
x-ray is normal (or has stable and inconsequential scarring) this management algorithm proposes 
initial diagnostic and focused and/or empiric management interventions for the four most 
common causes of chronic cough.  If response to focused and/or empiric intervention for the 
most common causes of chronic cough is inadequate, the algorithm suggests further diagnostic 
and treatment interventions. The 2006 ACCP guidelines also provide diagnosis and management 
recommendations for less common causes of chronic cough that might be suggested by the 
diagnostic assessment.  These less common causes of chronic cough will also be considered as 
part of the monitoring of the interventions for this study. 
 
A new patient visit in the cough specialty clinic most commonly includes the following as 
recommended by the 2006 ACCP guidelines: 
 
1. History and Physical Examination are performed, including an assessment of cough severity 
using a 0-10 rating scale with 0 being none and 10 being most severe. 
2. Recent chest x-ray is reviewed. 
3. Smoking and ACE-I status are evaluated; if present these issues are addressed. 
4. Cause(s) of cough is suggested. 
5. Suggested causes of cough are identified and indicated diagnostic evaluations are performed 
and/ or focused and/or empiric treatment is prescribed as recommended by the guidelines and 
within the context of the research subjects’ individual situation.  
6. Rationale for treatment is explained to the research participant. 
7. Actual treatment is explained to the research participant. 
8. Follow-up is planned. 
 
Initial management interventions for the 4 most common causes of chronic cough, if identified as 
a potential cause, include the focused or empiric use of: 
1. First generation antihistamine decongestants for upper airway cough syndrome;  
2. Inhaled corticosteroids and bronchodilators and leukotriene receptor antagonists for asthma; 
3. Inhaled corticosteroids for non-asthmatic eosinophic bronchitis; 
4. Acid suppression medication, diet and lifestyle changes for gastroesophageal reflux disease 
and the addition of prokinetic agents if the former do not result in adequate reduction of 
cough; 
5. Explanation of treatment and rationale for treatment; 
6. Use of query for the research participants understanding of explanations. 
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Intervention: Follow-up 
 
Follow-up visits for those with chronic cough most commonly include the following as 
recommended by the 2006 ACCP guidelines: 
 
1. Patient response to treatment (cough severity, side effects, tolerance of treatment) and 
adherences to intervention is assessed every 4-6 weeks either in person or by phone or via 
email. 
2. For those with ongoing cough, history and/or physical exam based upon the context of the 
individual’s situation and mode of follow-up are repeated seeking suggested cause of 
ongoing cough. 
3. Use of query and clarification related to patient’s understanding of the treatment, patient 
adherence to treatment, and patient response to treatment including side effects to treatment. 
Need to ask them about cough severity from 0 to 10 after establishing this baseline. 
4. Continuation of treatment, with escalation of one or more components of treatment until the 
patient provides self report of resolution or evident improvement of cough has been achieved, 
or de-escalation if warranted by side effects that outweigh the intervention benefits as 
reported by the patient or as observed by the interventionist.   
5. Inadequate response results in maintaining partially effective therapy, recognizing that there 
may be multiple concurrent causes of cough, or further optimizing therapy for each 
diagnosis.  
6. Additional testing for newly suggested cause of cough or for those not responding to empiric 
treatment. 
7. Provide interventions as per the ACCP guidelines for other diagnoses suggested to be 
causing chronic cough. 
 
Three Month Post Intervention Follow-up 
 
Research participants will be contacted by the PI 3 and 6 months after the initial interventionist 
visit for data collection. Additional reminders consisting of either email, postal letter, or a phone 
call will be conducted twice within the 4 weeks and then will be considered “missed data” at 4 
months.   
 
Debriefing Sessions 
 
The purpose of the debriefing sessions is to allow the interventionists the opportunity to share 
any thoughts they may have related to the intervention delivery and to allow the PI the 
opportunity to share any issues that might arise. Debriefing with the interventionists will occur 
either individually or in a group after the first and second 5 observed visits.  
 Providers will be given the opportunity to share their thoughts, asked how it is going, and 
asked to share any of their observations related to the PI being in the room during the 
research participant visit and asked if anything can be done better or if they have other 
related thoughts they would like to share.   
 The PI will also share her observations with a focus on large drift in intervention delivery, if 
any is identified for the study (but not for individual providers).   
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 Field notes related to that session will be recorded, in a form where interventionists are not 
identified in any way, by the PIs.   
 
 
Measures of Intervention Fidelity 
 
Intervention fidelity will be measured in 3 ways: 
 
1. Direct observation of interventionist and research participant visits by the PI for a total of 
12 random observations over the course of data collection.  Random numbers will be 
generated using SPSS to a total list of 56 numbers. The first 12 random numbers taken 
from this list will be used to identify the research subjects whose visits will be observed.  
The list will be maintained for use in the event of a research subject drops out.  Baseline 
observation data will be collected from the out of state patients who may not plan to 
return for in-person follow-up care and follow-up visits will be observed for local 
patients who plan to return for in-person follow-up care.  The observation goals are the 
measurement of the application of the ACCP cough management guidelines within the 
context of the patient visit.  Adherence and dose of intervention (content and delivery 
process) will be measured using a 0-3 point scale. See Appendix B. 
2. Patient self report of receipt of the information related to the guideline interventions 
prescribed using a 3 point scale.   See Appendix C. 
3. Concordance with patient self report and interventionist prescribed care will be 
established by chart review (Allscripts EMR).  The PI will rate degree to which the 
research participant’s self report of receipt of the intervention corresponds with 
documented prescribed interventions based upon medical record review.  A data 
extraction sheet will be used to rate the degree to which concordance is found using a 0-3 
point scale.  See Appendix D. 
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Appendix E 
Intervention Fidelity Monitoring Checklist for Observer to Use During Physician Visits 
Intervention Fidelity Monitoring Checklist 
Subject ID _________ 
Date ______________ 
Session _____   initial visit _____ follow-up visit  
 
a) _____Upper airway cough syndrome diagnosed and was 1st generation antihistamine  
           prescribed. If not, was reason given? 
b) _____Asthma diagnosed and was inhaled steroid, inhaled bronchodilator, or Singulair  
           prescribed. If not, was reason given? 
c) _____Non asthmatic eosinophilic bronchitis diagnosed and was inhaled steroid prescribed. If  
           not, was reason given? 
d) _____Gastroesophagel reflux diagnosed and was lifestyle change, diet, acid suppression  
            medication, and prokinetic agent prescribed. If not, was reason given? 
e) _____Other 
 
Context of the situation will be considered in deciding if intervention fidelity has been maintained 
(ex. side effects may result in inability to escalate treatment) 
Adherence 0= 
none 
1=low 
level of IF 
(addressed 
2 or less) 
2=  moderate 
level of IF 
(addressed 3) 
3= high 
level of IF 
(addressed 
all 4) 
Comments  
1. Was treatment prescribed 
by the physician according 
to the guideline (this 
includes was the patient 
evaluated per the 
guidelines for the 4 most 
common causes)? 
     
2. Did the physician probe 
for patient understanding 
of treatment 
     
3. Did the physician probe 
for patient response 
(including cough severity 
at baseline) and 
compliance? 
     
4. Did the physician 
maintain treatment if 
indicated? 
     
5. Did the physician step up 
treatment if indicated? 
     
6. Did the physician ordered 
further testing if 
indicated? 
     
7. Was follow-up arranged?      
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8. Field notes 
 
 
 
 
Ratings will be prorated and indicated as such based upon context especially for follow-up visits. 
This will be noted in the comments area. 
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Appendix F 
Intervention Fidelity Monitoring Questionnaire for Subject Receipt Evaluation 
Intervention Fidelity Monitoring Questionnaire 
 
 
Please check off the conditions that your physician advised you that are causing your cough. You 
may choose more than one condition. 
a) _____Post nasal drip  
b) _____Asthma  
c) _____Gastroesophageal reflux (stomach contents flowing backwards) 
d) _____Non Asthmatic Eosinophilic Bronchitis (a specific kind of asthma) 
e) _____Other_______________________________________ 
f) _____Other_______________________________________ 
 
Please check off the treatments that your physician advised you to use to control your cough. 
___ antihistamines and/or decongestants  
___inhaled steroids such as budesonide, fluticasone or similar medications 
___inhaled bronchodilators such as albuterol, salmeterol, fomoterol or similar medications 
___Singulair 
___Life style changes such as elevating the head of the bed, or avoidance of pets or similar issues 
___High Protein Low Fat diet 
___stomach acid suppression medications (Zantac or Ranitidine, Prilosec or Omeprazole,      
       Prevacid or similar medications) 
___Medicine to speed up stomach emptying (Reglan or Metoclopramide or similar medications)  
___Other please write in 
 
 
To what degree did your physician cover the following issues related to your chronic cough?   
(Response options: not covered, covered somewhat, covered completely).   
Please enter the number 
that best describes your 
situation. 
0= not 
covered; not 
given any 
information 
1= covered 
somewhat, would 
have liked more 
information 
2=  covered 
completely; given 
all the information 
I needed 
Comments (optional) 
1. Advise you of the reason 
for prescribed treatment to 
manage chronic cough 
    
2. Ask about your response 
to the treatment 
    
3. Ask about side effects of 
treatment 
    
4. Talk about the length of 
time you would need to 
continue to use the 
treatment 
    
5. Talk about the need for 
additional treatment if 
cough is still a problem 
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6. Talk about the  need for 
further testing if cough is 
still a problem 
    
7. Was follow-up arranged?  
 
 
    
 
 
    
Please enter the number 
that best describes your 
situation 
0= none of 
the time 
1=some of the 
time 
2=most of the 
time 
3= all of the time 
8. How closely have you 
followed the 
recommendations of your 
cough specialist? 
    
9. What recommendations did you not follow and why?  
 
 
 
 
10. Was any other treatment prescribed? 
 
 
11. Has anything changed related to your chronic cough experience since you began treatment at 
UMass Memorial? 
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Appendix G 
Measure of Concordance of Research Subject Self-Report of Intervention Delivery with 
Documented Prescribed Interventions based upon Principal Investigators Rating of Degree 
of Concordance 
 
Measure of Concordance of Research Participant Self-Report of Intervention Delivery with 
Documented Prescribed Interventions based upon Principal Investigators Rating of Degree of 
Concordance 
 
Subject ID _________ 
Date ______________ 
 
a) _____Upper airway cough syndrome diagnosed and was 1st generation antihistamine prescribed 
b) _____Asthma diagnosed and was inhaled steroid, inhaled bronchodilator, or Singulair prescribed 
c) _____Non asthmatic eosinophilic bronchitis diagnosed and was inhaled steroid prescribed 
d) _____Gastroesophageal reflux diagnosed and was lifestyle change, diet, acid suppression        
           medication,  and prokinetic agent prescribed 
e) _____Other 
 
 
Concordance No 
Agreement 
at all (0) 
Somewhat 
Agreement 
(1) 
Almost 
complete 
Agreement (2) 
Complete 
Agreement (3) 
Comments 
1. Did the subject and 
physician agree on 
diagnosis and treatment 
     
2. Field notes 
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Appendix H 
EMR Data Extraction Sheet 
EMR Data Extraction Sheet 
Subject ID 
 Medications / Management 
Interventions 
Diagnoses Field Notes 
Baseline  
 
 
 
 
 
 
 
 
  
3 Months  
 
 
 
 
 
 
 
  
 
